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The glandular structures of human skin have 
been classified according to the mechanism of secretion 
as bplocrine or wholly secretory (the sebaceous glands), 
and merocrine or'partly secretory (the sweat glands) 
(Ranvier,l887). Schiefferdecker (1922) further divided 
the merocrine glands into two sub -classes, the apocrine 
and the eccrine glands. The eccrine glands discharge 
a fluid secretion without loss of cellular constituents. 
In the apocrine glands the mechanism of secretion is 
more complicated, involving both a necrobiotic discharge 
and simple secretion. In mammals, with the exception 
of man, the apocrine glands are distributed widely over 
the body surface, while the eccrine glands are found 
only in certain restricted areas (e.g. the foot pad of 
the cat). In man, eccrine glands are present in large 
numbers in all areas, and it is the apocrine glands which 
are confined to particular regions, such as the axillee. 
The eccrine glands are tubular glands. The 
diameter of the tube is almost uniform in its whole 
length, the secretory part forming a closed coil. 
The duct opens on the skin surface by a corkscrew -like 
channel which pierces the epidermis. The tubule (but 
not the duct) is overlaid with regular longitudinal 
2. 
myoepithelium which probably helps to expel secretion 
from the gland (Richardson, 1949). The average number 
or glands per square cm. of skin is 100 - 300. 
SWEAT is a clear, alkaline, hypotonic solution of 
plasma crystalloids. (Way & Mennesheimer, 1940). 
The sodium chloride content ranges from 100 - 600 mgm.%. 
In secreting a hypotonic fluid the glands are performing 
osmotic work: their capacity to do this is increased by 
adrenal mineralo- corticoids (Conn et al.,1946: Conn 1949) 
and diminished by fatigue (Ladell, 1945). Kuno (1950a) 
has recently pointed out that the sweat ducts have a 
rich capillary blood - supply which suggests that the cells 
have some function other than the mere passage of sweet. 
There is no evidence that they are concerned in 
secretion, but histochemical studies indicate that 
reabsorption may occur in the ducts. It is tempting to 
think that they may be responsible for the selective re- 
absorption of sodium and chloride from the sweet. A 
comparison of the sweat gland with the nephron of the 
aglomerular kidney would be an interesting study. 
THE NERVE- SUPPLY TO THE SWEAT GLANDS. (Guttmann,1931: 
List & Peet,1938b). The secretory activity of the sweat 
glands is under nervous control. From the anatomical 
point of view, the sweat fibres are sympathetic, leaving 
the spinal cord in the anterior roots D 1 - L 2 and 
relaying in the sympathetic ganglia. Post- ganglionic 
fibres to the trunk and limbs rejoin the spinal nerves 
and are distributed with the cutaneous sensory nerves. 
(White,1930b: Woollard &, Phillips,1932). Fibres to 
the head and neck, after relaying in the cervical 
ganglia (L.Guttmann,1940), run in the carotid plexuses 
to join the peripheral branches of the fifth cranial 
nerve distal to the sensory root (List & Peet,1938d). 
The existence of accessory sudomotor fibres of bulbar 
origin has been 'suggested by Wilson (1936). 
Spinal sympathetic dermatomes were studied by 
Foerster (quoted by List & Pimenta, 1944) and proved to 
be much larger than the corresponding sensory dermatomes, 
'preganglionic fibres from each root being distributed to 
four or five ganglia. L.Guttmann, (1938) found 
disturbances of sweat secretion in D 7 - 9 dermatomes in 
three patients with gall -bladder disease ( "der Viszerosud- 
orale Reflex "), and pointed out that there might be a 
dissociation between the area of sweat disturbances and 
Head's area of sensory disturbances. Reflex sweating of 
segmental distribution has also been described in angina 
pectoris (R.S. Palmer,1930). 
The sympathetic fibres to the upper limb which 
are derived from segments D 2 - 6 or below, all pass 
through the second dorsal ganglion (Atlas, 1941: 
Smithwick,1942: Hyndman & Wolkin,1942a). This makes 
it possible to interrupt the sympathetic pathway to the 
hand without injuring the cervical sympathetic fibres 
which leave the cord in the first dorsal root and pass 
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upwards through the stellate ganglion. Removal of the 
second dorsal ganglion (Hyndman & Wolkin, 19428) or 
division of the sympathetic chain below the third dorsal 
ganglion combined with section of either the white rami 
communicantes to the second and third ganglia (Telford, 
1935) or the second and third spinal nerves (Smithwick, 
1940b) abolishes all sweating in the upper limb. Since 
most of the cell' stations are situated in the stellate 
ganglion these operations are essentially preganglionic 
interruptions of the pathway. The fibres to the lower 
limb have a longer course, leaving the cord at the level 
of D 10 - L 2 and relaying in the lumber and sacral 
ganglia. Lower limb sympathectomy is also preganglionic, 
consisting in the removal of a section of the lumbar chain 
which usually includes the second, third and fourth 
lumbar ganglia. It has recently been shown (Boyd & 
Monro 1949) that in the lower dorsal and upper lumbar 
regions there are accessory sympathetic ganglia within 
the anterior primary rami. These ganglia are surgically 
inaccessible so that even after extensive thoraco- lumbar 
sympathectomies sweating may persist on the lower abdomen 
and thighs. 
The mode of termination of autonomic nerve fibres 
has been studied by several techniques. Hillarp (1946) 
employed a methylene blue staining method to study the 
morphology of the pericellular apparatus. He found that 
the axons broke up into terminal ramifications which 
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entered a "nervous ground plexus" within a network of 
anastomosing strands formed by a terminal Schwann 
plasmodium. This was directly superimposed on the 
effector cells, so that each cell was in contact with 
some part of it. The plexus was discontinuous suggesting 
that the system was organised into "neuro- secretory units" 
analagous to motor units. Several axons contributed to 
each unit. This conception was supported by experimental 
observations on partially denervated salivary glands 
(Hillarp, 1949 - see page 61). The pattern of the local 
sweat response to faradic stimulation which is due to a 
local nervous mechanism (Bickford 1938: Wilkins et al. 
1938) also suggests that the terminal arborisations of 
the sweat fibres, though extensive, do not anastomose 
freely, the response usually covering an area of 5 - 15 sq,cm. 
THERMAL SWEATING: 
Experimentally, thermal sweating can be induced in 
three ways: by direct heating, by reflex heating and by 
raising the environmental temperature. Intense heat is 
needed to produce a direct respdnse from the sweat glands 
and it is unlikely that this mechanism has any physio- 
logical significance: the critical surface temperature 
in Randall's (1947) experiments was between 39° and 45 °C. 
By reflex heating is meant, for example, immersing both 
feet in hot water and studying the response in the upper 
limbs. After a latent period of 5 - 15 minutes vaso- 
dilation occurs in the hands and there is e rise in skin 
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temperature. Later generalised sweating appears. It 
has been shown that two factors are concerned in this 
response: the return of warmed blood to the hypothalamus 
and afferent nerve stimuli from the heated area (Ladell, 
1945: Randall et al., 1948). There is evidence that 
the efferent nerve pathway is not the same as for the 
sensation of. warmth (Issekütz et al.,1950). Cooling a 
limb inhibits thermal sweating by a reflex nervous 
mechanism. The critical level of environmental 
temperature for thermal sweating varies of course with 
the endogenous heat production. For normal subjects 
under basal conditions it is about 880F. (31 °C.) 
Bazett (1950) described superficial (dermal) and 
deep (subcutaneous) temperature receptors, the latter 
being related to the deep venous plexus draining blood 
from the muscles. He suggested that the reflex response 
to external heating, in which the superficial receptors 
are stimulated, differs from that to internal heating 
(muscular exercise). In the first case the response is 
primarily vasodilator and sweating does not supervene 
until surface temperature exceeds 34 °C: the second type 
of response utilizes sweating which is proportional to 
the existing surface temperature and maintains, rather 
than alters it. 
The activity of individual sweat glands during sub - 
maximal thermal sweating has been studied by Kuno (1934, 
1938) end by Randall (1946). It has been found that 
Footnote, page 7. A rise in skin temperature may also 
be a factor (Robinson et al.,1950). 
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the glands work in relays and are in addition subject 
to a general waxing and waning of activity which occurs 
simultaneously on various parts of the body surface and 
is obviously under the control of a centre, probably in 
the hypothalamus. As the environmental temperature is 
raised, more and more glands are called into action until 
a maximum is reached: further increase in the sweat 
response is achiéved by raising the rate of secretion of 
individual glands. It has been calculated that 
individual glands can secrete up to 0.01 mgm. /min. 
(Randall & McClure, 1949). A total of three litres 
may be secreted in an hour during maximal sweating. 
Such a high rate of secretion cannot be maintained for 
long: even if water and salt are replaced by drinking, 
secretion begins to fall off after about an hour. The 
sweat electrolyte content rises as the glands fatigue, 
owing to their diminished capacity for osmotic work. 
Another factor, to which Kuno (1950b) has drawn attention, 
is the increased gradient against which the cells have 
to operate owing to the high local concentration of NeCl 
in the extracellular fluid. 
Evaporation is most efficient when the relative 
humidity of the environment is low and ventilation good. 
In e still, humid atmosphere little evaporation occurs 
and it has been suggested by Kuno (1934) that the 
inhibition of 'sweating which occurs in heat stroke may 
be an attempt to protect the body against a nett gain in 
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heat due to an intense activity of the sweat glands. 
A good blood supply to the skin is needed for 
continued sweat secretion. If a tourniquet is applied 
to a sweating limb secretion falls off to very low levels 
after 10 - 30 minutes. An interesting observation 
arising out of this kind of experiment is that release of 
the tourniquet is followed by temporary inhibition of 
sweating on the opposite limb, due presumably to release 
of some humoral agent into the circulation from the 
ischaemic area. This agent probably acts centrally 
and not peripherally, since the inhibition of sweating 
on the opposite arm is not prevented by occluding the 
circulation to that arm immediately before release of 
the opposite cuff. (Randall et al. 1948). Patients 
with congestive heart failure have been found to sweat 
less than normal subjects in a subtropical climate 
(Burch, 1946). 
The response to heating is modified by repeated 
exposure to high environmental temperatures over a period 
of 10 - 14 days. The process of acclimatisation to 
heat involves important cardiovascular adjustments as well 
as changes in the sweat mechanism itself. There is an 
increase in extra -cellular fluid volume and in cardiac 
output. On exposure to heat sweating is more profuse: 
it appears after a shorter latent period and at a lower 
rectal temperature. The sodium chloride content of the 
sweat is reduced by 60 - 700. Conn (1949) has shown 
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that the fall in sweat iVaC1 is accompanied initially 
by a fall in urinary i '4aCl and by a negative nitrogen 
balance. Later the urinary electrolyte output returns 
to its original level, although the sweat i'aCl remains 
low. These metabolic changes can be reproduced by 
giving pituitary adrenocorticotrophic hormone (ACTH). 
Conn et al. (1946) had previously shown that the 
salt content of the sweat was reduced by desoxycortico- 
sterone acetate (DOCA). The response of the sweat 
glands is not so prompt as that of the renal tubules: it 
is apparent about 18 hours after intramuscular injection. 
The two structures also differ in their capacity to 
maintain the response: whereas the urinary salt output 
"rebounds" after 2 -3 days despite continued administration 
of DOCA, sweat Nadi remains at a low level as long es the 
hormone is given. When DOCA or ACTH is discontinued 
sweat NaCl rises far above the initial level, presumably 
owing to depression of endogenous hormone production. 
Conn and other workers also found that the sweat sodium 
was high in patients with Addison's disease and low in 
Cushing's syndrome.(1948) 
The regional distribution of thermal sweating has 
been studied by several workers. Kuno (1934) gives the 
order of degree of sweating as 1) forehead, neck, some 
larger areas of anterior and posterior surface of trunk, 
lumbar region, dorsum of hand and adjacent part of fore- 
arm, 2) cheek, lateral surface of trunk and the greater 
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part of the extremities, 3) internal femoral regions 
and axillae, 4) palms and soles. These results have 
been confirmed by Burch & Sodemann (1943) and by 
Weiner (1945). It can be seen that the areas which 
sweat relatively little in response to thermal stimuli 
are those unfavourably situated for evaporation. 
Sweating on the palms and soles may actually diminish as 
a result of heating. Conversely, mental and emotional 
stimuli which elicit sweating on these areas may 
temporarily inhibit thermal sweating. 
EMOTIONAL OR MENTAL SWEATING. 
This form of sweating is most conspicuous on the 
palms of the hands but also affects the soles of the 
feet and, in some individuals, the axillae. It is 
elicited by e variety of mental and emotional stimuli, 
all more or less unpleasant, such as pain, fear, 
embarrassment and mental arithmetic. Extreme mental 
stress or violent sensory stimulation causes sweat to 
appear on the whole body surface. A similar general 
sweating can also be caused by minor sensory or emotional 
stimuli when the surrounding temperature is high. 
Mental sweating appears suddenly and does not 
progress. When the stimulus is over it rapidly declines. 
The psychogalvanic response was first described by 
Fers (1888). This response is the reduction in resistance 
of the skin to the passage of a low -voltage direct current 
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following various sensory stimuli. It is most easily 
recorded from the fingers and toes, but under favourable 
conditions can be obtained from all parts of the body 
surface. Carmichael and others (l9488) have shown that 
it has two components - sweat secretion and vaso- 
constriction. Changes in skin potential in response 
to psychological and other stimuli were reported by 
Tarchanoff (1890), and have been studied by Goadby & 
Goadby (1936, 1949). This e.m.f. response depends on 
unknown mechanisms, which do not include vasoconstriction 
(since exsanguination of a limb leaves the response 
temporarily unaffected). Like the resistance response 
it is abolished by sympathectomy. Potentials recorded 
from the cat's foot pad after induction shocks applied 
to the lumbar sympathetic are of very brief duration; 
"tetanisation" is not obtained until the frequency of 
stimulation approaches 150 /min. (Richter & Whelan, 1943). 
It is claimed that the brief, monophasic nature of the 
response implies that it does not depend on the moisture 
liberated but rather on a change in permeability ( ?) of 
the sweat glands as they become activated. 
Darrow (1937) has reviewed the neural mechanisms 
controlling palmar sweating. It can be elicited by 
stimulation of the premotor cortex. In man bilateral 
ablation of area 24 and part of area 32 may be followed 
by diminished sweating of the extremities (Pool, 1949). 
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CHEMICAL STIMULATION OF SWEAT GLANDS 
The chemical transmitter at the sweat nerve -endings 
is acetylcholine (ACh). Dale & Feldberg (1934) showed 
that ACh appeared in the venous effluent of the perfused 
cat's foot when sweating was elicited by nerve stimulation. 
Sweating is inhibited by atropine. 
Administration of peresympathomimetic drugs causes 
a secretion of sweat. The older observations were 
made with pilocarpine. There was a prolonged controversy 
about the exact site of action of this drug, some main- 
taining that it stimulated the gland cells directly, and 
others that it acted on the nerve - endings to cause a 
release of ACh. Langley (1922) showed that the response 
to intradermal injection of pilocarpine in the footpad 
of the cat was retained after nerve section and degener- 
ation. He attributed the failure of other workers to 
get responses after denervation to the administration of 
the drug by remote subcutaneous injection and to the 
difficulty of detecting responses in adult cats with 
heavily keratinised pads. The direct'action of pilo- 
carpine on the sweat glands was also demonstrated by 
Hinsey & Cutting (1934) in the cat, and by Wilson (1934, 
1936), Gurney & Bunnell (1942), and Palmer (1947) in 
human subjects. 
In man subcutaneous injection of pilocarpine often 
causes nausea and urinary urgency in doses which produce 
 
little or no generalised sweating. Acetylcholine 
itself has of course no general effects when given 
subcutaneously owing to its rapid destruction by the 
true cholinesterase present in the blood and tissues. 
Acetyl -beta- mettylcholine (mecholyl) is more stable; 
but, like pilocarpine, it causes undesirable side effects. 
Carbaminoyl -choline (carbechol) has a specially powerful 
action on the bowel and bladder. Furfur- trimethylemmonium 
iodide (furmethide) is a parasympethomimetic substance 
described by Myerson et al. (1940) and Fellows & 
Livingstone (1940). According to S.A. Guttmann (1944) 
it can be relied on to produce generalised sweating 
without unpleasant side effects when injected subcutane- 
ously in a dose of 5 mgm. 
Local stimulation of sweat glands by paresympatho- 
mimetic agents introduced into the skin by intradermal 
injection or iontophoresis is discussed in the following 
section. Koppanyi (1945) has recently advocated the use 
of e weakly muscarinic diene alcohol (hexedienol) which 
is effective when applied to the skin surface. 
Now known as Methacholine. 
q 
The original aim of the present work was to find 
out how far overactivity of autonomically innervated 
organs was due to: 
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(1) overaction of nervous control 
(2) excessive sensitivity to the chemical transmitter. 
The sweat glands were chosen owing to their accessibility 
for observation and for injection and the relative 
simplicity of their response to drugs. They have the 
further advantage of being easily isolated from their 




MEASUREMENT OF SWEAT RESPONSES. 
A number of methods have been described for the 
measurement of sweet gland activity. 
Weighing. The whole body can be repeatedly weighed 
on a Sauter balance (which has an accuracy of 0.1 Gm.). 
The difference in weight less the water content of the 
expired air less the amount by which the weight of CO2 
eliminated exceeds the weight of oxygen absorbed 
represent the total water loss from the skin. (At low 
environmental temperatures this comprises the sweat 
secreted by palmar and plantar glands (less than 5 %) 
and the insensible water loss through the rest of the 
skin. (d'Alton et al., 1948). 
Sweat collections. Regional differences in the rate of 
sweating have been studied by Kuno (1934) and by Weiner 
(1945) whose method was to collect sweat in shallow brass 
cups and to determine the weight gain of absorbent swabs 
with which the cups were mopped out. The mean output 
of individual sweat glands has been measured by Randall 
& McClure (1949) by means of simultaneous sweat 
collections and iodine -starch paper tests (see below). 
This proved to be of the order of 10 microgrammes /min. 
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during maximal stimulation. A really elegant technique 
was described by Neumann, Cohn and Burch (1941), in 
which sweat is picked up from a chamber applied to the 
skin by a current of dry oxygen, and recondensed in a 
series of cooled aluminium coils which were weighed at 
the beginning and end of the observation. An illustra- 
tion of this apparatus appears in the paper by Burch & 
Sodeman (1943). 
There are numerous colorimetric methods for the 
detection of sweating and some of these have been 
adapted to yield semi -quantitative results. The 
original method was that described by Minor in 1927 in 
which a starch- iodine mixture is painted on the skin 
and turns blue in the presence of sweating. Later 
L. Guttmann introduced Q.uinalizarin powder which changes 
on wetting from grey to an intense purple. These 
methods lend themselves to Photographic recording and 
provide beautiful illustrations to the series of papers 
by List & Peet (1938 -9) and to Guttmann's (1931) review. 
We have made use of a modification of Minor's (1927) 
method described by Randall (1946) in which the skin is 
painted with 3% iodine in 95% alcohol and a piece of 
starch paper is applied to the test area for - minute. 
Each active sweat gland shows as a tiny, dark blue point 
on the paper. The number of dots is counted with a lens: 
their size gives an impression of the rate of secretion 
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from individual glands. The iodine must be renewed 
frequently, otherwise the dots become very faint. To 
avoid smudging it is best to hold the paper on the skin 
with forceps. Similar prints can be made with tincture 
of ferric chloride and tannic acid paper (Silverman & 
Powell, 1944), and with untreated paper applied to the 
skin, floated in ,silver nitrate solution and "developed" 
in ultra- violet light. (Gurney & Bunnell, 1942). We 
even found it possible to visualise sweating by painting 
the skin with 10% starch and sodium hypochlorite and 
incorporating 5% sodium iodide in the test injection. 
We hoped to measure the latent period in this way but 
the colour reaction developed too slowly. 
The measurement of skin electrical resistance 
was introduced in Charcot's clinic many years ago 
(Vigouroux, 1879). Minor (1927) recommended it as a 
substitute for the colorimetric method in negroes. 
Richter & Levine (1929, 1937) have established that the 
skin resistance depends on the activity of the sweat 
glands and is greatly increased by their denervation 
in both monkeys and human subjects.' Reference has 
already been made to the proof by Carmichael et al. (1940e) 
that reflex vasoconstriction as well es sweating causes 
a fall of the skin resistance. In the conditions of 
our experiments a fall of skin resistance has always 
indicated sweating except where the skin has been 
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injured or where a powerful vasoconstrictor has been 
injected. Alternate electrical and iodine- starch 
paper readings agree very well on the whole (Table 6), 
except that a) an aggregation of secreting glands round 
the point of puncture may be missed by the exploring 
electrode so that the current recorded is proportionately 
too small or b) a small number of actively secreting 
glands may wet the skin enough to give quite a large 
fall in resistance. The two readings diverge seriously 
only in the adrenaline experiments (Table 6) for reasons 
discussed above. Taken together they constitute a 
very reliable technique for detecting sweating. The 
particular virtue of the electrical method is that 
readings can be taken quickly from a number of control 
areas as well as from the injection site so that the 
reflex sweating which occasionally follows the needle - 
prick can be easily distinguished from a direct action 
of ACh on the sweat glands. This reflex sweating may 
be generalised or localised. In the first case it is 
due to e central reflex and is strictly comparable to 
the psychogalvanic response on the fingers: in the 
second case it extends over an area of 5 - 15 sq.cm. and 
resembles the sweat response to faradic stimulation 
described by Bickford (1938) and Wilkins et al. (1938) 
and attributed by them to an axon reflex. The time 
course of these reflex responses is quite different from 
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that of the response to chemical stimulation, the 
reflex sweating appearing almost instantaneously.end 
quite quickly dying away, while the direct response 
has an appreciable latency, continues to increase for 
a minute or two, and lasts 10 - 20 mins. or longer. 
Any well- marked response which quickly decays (or any 
response which is 'out of series') is an indication for 
repeating the injection. There is one chemical 
substance which appears to cause responses of the axon 
reflex type, namely nicotine - this will be dealt with 
in a later section. 
The apparatus used for electrical measurements is 
extremely simple. It consists of a 9 V. battery 
connected to two electrodes through a variable resistance. 
The current flow is registered by a galvanometer reading 
0 -24 micro -amps. in 0.2 micro -amps. divisions. The 
electrodes are a saline pad incorporating a chlorided 
silver wire, which is strapped to the upper arm, end a 
silvered brass disc of 15 mm. diameter, with a non- 
conducting handle, which is applied lightly to test §nd 
control areas. Needle punctures must be carefully 
avoided as there is a risk of damaging the galvanometer 
owing to the very low resistance at the puncture site. 
If the exploring electrode is too small it tends to 
leave an impression on the skin so that after repeated 
applications e fall of skin resistance due to trauma 
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occurs. This circuit does no 'of course, measure 
skin resistance directly: for that a more elaborate 
circuit is required (Smithwick, 19408). But since 
we ere concerned only with changes in resistance or 
differences between one area of skin and another, it is 
enough to record the amount of current flowing through 
the test area when control readings on non -sweating 
areas are 0 - 0.2 micro -amps. (Haxton, 1947: Barcroft & 
Hamilton, 19488ó) The resistance of the tissues other 
than the skin is relatively small, so that it is immaterial 
to which arm the indifferent electrode is attached. 
Application of Drugs to the Sweat Glands 
Intravenous infusion. - since it was important to study 
the sensitivity of the sweat glands on the palm of the 
hand, where intradermal injections are apt to be painful, 
a few preliminary experiments were done in which mecholyl 
and acetylcholine were given intravenously. The drugs 
were given by slow infusion with a constant speed 
infusion apparatus. Weiss & Ellis (1934) reported 
that 20 mgm /min. of ACh constantly produced minimal 
effects and that the corresponding dose of mecholyl was 
0.1 mgm /min. Carmichael &:,eraser (1933) emphasised 
. 
the pronounced variability of the response to ACh. We 
found (in six subjects) that with mecholyl at rates 
below 0.1 mgm /min. the only effect was flushing of the 
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face and local flushing and sweating over the vein. 
At e rate of 0.125 mgm /min. there was in addition 
increased salivation, slight tachycardia and tightness 
in the chest. At 0.15 mgm /min. sweating appeared but 
was confined to the forehead and cheeks. In one subject 
the rate was increased to 0.3 mgm /min. without producing 
increased sweating of the hands. Acetylcholine was 
given to two subjects. No effect was observed with 
rates of infusion up to 32 mgm /min. 50 mgm /min. 
produced flushing of the face and a slight feeling of 
constriction in the chest. With 75 mgm /min. there was 
a marked feeling of warmth and flushing, tachycardia, 
end a sense of constriction in the chest. Sweating 
broke out on the forehead, nose and upper lip but there 
was no increased sweating of the palms or forearms. 
Intradermal injection. - It was clear from these results 
that intravenous infusions were unsuitable for testing 
the sensitivity of the sweat glands. We therefore 
turned to local injection of parasympathomimetic drugs. 
To minimise trauma special short -level intradermal 
needles were used (Hawkins 4i /lOmm. x 2 inch) end only 
a minute volume of solution was injected. This was 
usually 0.01 cc. measured by en "Agla" micrometer 
syringe. The needle was pushed along in the skin for 
about 1 cm. before making the injection, so that it would 
be possible to avoid the point of puncture in taking 
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electrical readings. After withdrawing the needle 
the area was carefully dried. We aimed at making a 
deep intradermal injection so as to get as near the sweat 
glands as possible. When we came to check this point 
by Indian ink injections in the cadaver it was found 
that some of the injections were actually subcutaneous, 
although most of,them were shown histologically to be 
well placed in relation to the glands. In the case of 
acetylcholine depth of injection does not seem to be very 
important (Table 1) provided a) it is not so superficial 
as to traumatise the epidermis and b) not so deep es to 
be actually below the deep fascia. 
Sites of injection. - The flexor surface of the forearm 
well above the wrist was the site most often used for 
injections. In a cool environment (R.T.= 18 -20 °C) this 
area does not sweat spontaneously end so provides a good 
background against which responses can be studied. 
After eliminating pain sensation and spontaneous sweating 
by blocking afferent sensory and secretomotor impulses 
in the median nerve with procaine, it was also possible 
to study responses on the palm of the hand. In Table 2 
responses to 0.01 cc. of mecholyl 10 "injected at two 
sites on each forearm are compared. It can be seen 
that the response is greater in this case on the right 
side than on the left; there is a smaller difference 
between the second pair of sites and the first. Table 
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shows the variation between one forearm and the other 
in six subjects tested with acetylcholine. On the 
whole the differences are small, the smallest effective 
concentration lying within a tenfold range on the two 
sides. Rather larger differences appeared when palm 
and forearm sensitivities were compared (Table 4), the 
palmar glands tending to respond to smaller concentrations 
than those on the forearm. Krause (quoted by Kuno, 1934) 
found 2736 glands per square zoll (? 11 sq_.cm.) on the 
palm compared with 1123 on the flexor surface of the fore- 
arm. Now it is obvious from the study of starch paper 
prints that individual sweat glands vary in their 
sensitivity to acetylcholine. If the numbers of glands 
sensitive to different concentrations of ACh are distri- 
buted in the same way, one would expect to find more 
glands capable of responding to very low concentrations 
of ACh on the palm than on the forearm. 
Preparation of solutions. - The results of injecting 
slightly different concentrations of ACh (see Table 3, 
subject J.A.F.) were rather inconsistent. Because of 
this, and because of the variations in sensitivity 
between the two sides and between different sites on the 
same forearm, it was clearly impossible to work to the 
same degree of accuracy as if one were studying isolated 
tissues. Since differences of less than tenfold in the 
smallest effective concentration of ACh were unlikely to 
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be significant we decided to make up serial tenfold 
dilutions end to omit the testing of intermediate concen- 
trations. The conventional notation of 10- 3(= 1:1000), 
10 -4( =1:10,000), 10 -6(= 1:1,000,000) etc. has been used. 
Crystalline acetylcholine hydrochloride (Roche) 
was used. The need to prepare sterile solutions for 
injection introduces certain difficulties. Owing to 
its instability Acetylcholine has to be made up freshly 
for each experiment. It is inconvenient to sterilise 
pipettes and flasks frequently for this purpose. Dilu- 
tions made with sterile syringes and stored in test 
tubes are reasonably accurate provided precautions are 
taken against the adsorbing effect of the glass. We 
suspected that our dilutions were unreliable at e very 
early stage, when we were getting responses to fantastic- 
ally low concentrations of ACh. Although the reservoir 
of saline was changed frequently, the same syringe was 
being used to dilute from 10 -1 to 10 -15. When solutions 
prepared in this way were compared on the frog rectus by 
Dr.F.Hobbiger with solutions prepared with a series of 
pipettes and flasks, it was found that the syringe 
solutions deviated progressively from the expected line 
below 10 -5 and that below 10 
-7 
scarcely any further 
dilution occurred (Fig. 1.). Presumably ACh ions are 
adsorbed by the glass from concentrated solutions and 
come off again into dilute solutions. No amount of 
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washing out will get rid of this source of error. 
One must either treat the glass ware with a non -adsorbent 
substance such as silicone or else use a series of 
syringes in preparing solutions. The concentration of 
ACh in a solution prepared by the multiple- syringe 
method and purporting to contain 10 -7 was found to be 
1.2 x 10 -7 by comparison with a solution prepared by 
the pipette - and -flask technique. The solutions were 
compared on the frog rectus preparation by Dr.Hobbiger. 
A similar comparison on human sweat glands also gave 
satisfactory results. (Table 5). It was thus clear 
that the multiple - syringe technique was sufficiently 
accurate for our purposÿs, and we have used it throughout 
the whole of the work to be described. Similar precau- 
tions were observed with the syringes end needles used 
for giving the injections. Where e syringe was used 
more than once it had previously contained a weaker, and 
not a stronger solution. of the same drug. 
The diluent used was sterile normal saline with a 
pH of 5.5 - 6.0 (glass electrode). This produces no 
response when injected into the skin. 
In one or two experiments drugs were introduced into 
the skin by iontophoresis (Wayne, 1955). This method 
of course gives qualitative results only, but it is 
particularly useful for atropinising an area of skin 
where injection would be painful. Carmichael et al. 
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(1940 ) for example, used it to demonstrate that the 
psychogalvanic response could still be obtained from 
the finger -tip after all sweat - gland activity had been 
suppressed by atropine, proving that the response had e 
vasomotor component. The method was also very ingeni- 
ously used by Barcroft and co- workers (1943), in their 
plethysmographic studies of muscle blood flow, to blanch 
the skin of the entire forearm with adrenaline. Most 
autonomic drugs can be introduced into the skin in this 
way, and there are papers describing iontophoresis of 
pilocarpine and adrenaline (Giraudeau, 1931 and 
Ackermann, 1936, 1938), mecholyl (Martin, 1937) and 
dibenamine (Last et al., 1949). We have been able to 
produce local sweating by iontophoresis of acetylcholine 
and carbachol as well as mecholyl. A current density 
of 1 mA /sq.cm. for about 10 mins. was suitable, the 
anode being the same brass electrode used for skin 
resistance measurements with a pad of filter paper 
soaked in a 10 -3 or 10 -4 solution of the drug applied 
between it and the skin. 
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SUMMARY 
Methods of measuring sweat responses are reviewed. 
In the present work both the iodine- starch paper test 
end the skin electrical resistance test have been 
employed. 
Intravenous infusions of acetylcholine (ACh) and 
mecholyl were found to be unsuitable for testing the 
sensitivity of the sweet glands because of unpleasant 
side effects. 
The technique used for intradermal injections is 
described. Injections were made into the flexor 
surface of the forearm and, after procaine block of the 
median nerve, into the palm of the hand. Variations 
in response between different sites of injection have 
been recorded. 
The preparation of dilute solutions of ACh requires 
special precautions to avoid the effects of adsorption 
of ACh on to glassware. 
Examples are given of the value of iontophoresis. 
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CHAPTER 11. 
THE RESPONSE TO ACETYLCHOLINE. 
The injection of a small volume of acetylcholine 
or mecholyl solution into the skin constantly produced 
a sweat response which was roughly proportional to the 
concentration injected. The response was inhibited by 
intravenous and local atropine (Tables 7 and 8), and 
potentiated by anticholinesterases (Table 9). Using 
progressively weaker solutions it was possible to 
determine a threshold concentration below which no 
response was elicited. 
Nicotine -like effects. 
It has been claimed (Coon x Rothman, 1941) that 
locally injected ACh stimulates the sweat glands by two 
mechanisms: a) A direct muscarine -like action on the cell 
receptors: b) a nicotine -like action on the nerve 
endings producing an axon reflex. The efferent side of 
the axon reflex of course involves transmission by ACh 
so that both types of response would be abolished by 
atropine. The evidence accumulated by Rothman and his 
co- workers very strongly suggests that reflex sweating 
to ACh can occur, but we have never been convinced that 
sweating occurred in our subjects beyond the probable 
area of diffusion of ACh. On the other hand, we have 
occasionally seen reflex pilomotor stimulation with 10 -2 to 
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10 -4 ACh, another axon reflex described by these 
workers, (Coon & Rothman, 1940). We have also 
confirmed that nicotine can stimulate sweating by this 
mechanism, (Table 14). The response in subject J.H. 
was obtained in spite of blocking the cutaneous nerve 
with procaine and extended over an area 2-3 cm. in 
diameter. It appeared abruptly and quickly decayed. 
The blocking effect of Tetraethylammonium (TEA), which 
was noted by Janowitz & Grossman (1949) but denied by 
Issekutz et al. (1950), is easily demonstrated provided 
the TEA is injected some minutes before the nicotine 
(Table 14). A response was elicited 20 days after upper 
dorsal 
sympathectomy (Telford operation) in one subject. This 
confirms the view advanced on anatomical grounds (p.4 ) 
that the section is preganglionic. These effects of 
nicotine and ACh on sympathetic terminals are comparable 
with the centripetal discharges set up in sensory 
afferents by close infra-arterial injection of nicotine - 
like substances (Brown & Gray, 1948). 
Comparison of ACh and mecholyl thresholds (Table 10) 
gave a rough idea of their relative potency. The mean 
mecholyl threshold in this small series was 10 -6, the 
mean ACh threshold being somewhat under 10 -4. Mecholyl 
is therefore about 200 - 400 times more potent than ACh 
by intradermal injection. This agrees well with the 
relative potency of the two drugs given by intravenous 
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infusion, 0.125 mgm /min. of mecholyl end 50 mgm /min. 
of ACh producing comparable effects. The maximum 
potentiation of ACh by anticholinesterases was of the 
order of a hundredfold or less, so it seems likely 
that the high relative potency of the beta- methyl ester 
is due to something more than its resistance to 
enzymatic hydrolysis. It would be interesting to 
compare the two drugs in skin areas previously treated 
with an anticholinesterase. 
The time course of the response to mecholyl and 
ACh was rather different as one would expect, the 
mecholyl response decaying much more slowly (Fig. 2). 
With both drugs there was a latent period of 10 - 30 
seconds before the response appeared. 
Variations in Response. 
With the object of imitating the release of the 
natural chemical transmitter as closely as possible, 
acetylcholine itself was used in most of the experiments 
to be described. The smallest effective concentration 
was determined in 50 normal young adults (25 of each sex). 
In 47 subjects the ACh threshold was between 10-3 and 10 -6: 
one responded on repeated occasions to 10 -7 and one 
required 10 
-2 
to produce a response. Only one failed to 
respond to 10 -2 ACh. (Table 11). There was no significant 
sex difference, in contrast to the findings of Gibson & 
Shelley (1948) who studied the iodine starch paper count 
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after injecting fixed concentrations of ACh and 
pilocarpine and reported that the sweat glands in 
females were much less responsive than in males. Kahn 
& Rothman (1942), using Minor's method to visualise 
sweating, reported negative to slight responses to 10 -3 
ACh in 90% of 41 women compared with moderate to very 
strong responses in 95% of 59 men. The differences 
may have been due to a diffusion effect since we were 
able to spread the response to e given concentration 
of ACh over a wider area of skin with hyaluronidase, 
although we could not usually lower the ACh threshold 
(Table 12). On the other hand, Janowitz & Grossman (1950) 
studied a small group of males and females and found that 
the ACh threshold was about 10 in the women compared 
with 10 -5 in the men. Since only five subjects of each 
sex were tested little significance can be attached to 
this result. 
Myerson, Loman & Rinkel (1937) gave mecholyl to a 
number of schizophrenics and noted that some patients in 
whom 10 -3 was enough to produce visible sweating in 
summer required 5 x 10-3 for a "good response" in 
November. We also noted a tendency for the ACh threshold 
to fall in summer (Table 13), Subject G.M.'s threshold 
was followed repeatedly over a twelve month period and 
fell from 10 -3 in January to 10 -5 in July and August, 
returning to 10-3 in November. (All observations were 
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made at approximately the same room temperature). I 
hoped to be able to show that the increased sensitivity 
of the glands is associated with acclimatisation to heat, 
but have not yet had an opportunity to study subjects 
under suitable conditions. Conn (1949) showed that the 
process of acclimatisation involves increased secretion 
of pituitary adrenocorticotrophic hormone. There is 
indirect evidence that this is not the humoral agent 
concerned in the seasonal variations in ACh threshold 
since one of our patients with hypopituitarism and 
another with Addison's disease responded to low concen- 
trations of ACh. 
With the exception of one woman aged 31 with 
congenital anhidrosis in whom complete lack of response 
to ACh was associated with absence of sweat glands on 
biopsy, there was no correlation between sweat function 
and sensitivity to ACh. Some subjects who sweated 
normally in hot weather were relatively unresponsive to 
injections and others with marked hypohidrosis proved 
to be quite sensitive. Patients with hypopituitarism 
and hypothyroidism had thresholds as low as 10 -6 ACh. 
Comparison of hyperhidrotic subjects with a control 
group revealed no difference in the range of ACh threshold. 
(See page 69) . 
Differences in ACh threshold are not due to varia- 
tions in the cholinesterase content of the skin. The 
rZrZ Vt.., 
maximum potentiation of the ACh response by anti - 
cholinesterases was of the order of a hundredfold. 
The ACh threshold, on the other hand, varied over a 
range of more then a hundred- thousandfold. Moreover, 
potentiation was obtained in sensitive as well as 
insensitive subjects. 
Until more is known about the factors which delay 
the onset of the response to injected ACh (pp.38 -42 ), 
the significance of variations in sensitivity cannot 
be assessed. 
Potassium. 
The release of ACh at peripheral cholinergic nerve 
endings by intro- arterial injection of potassium chloride 
was demonstrated in the cat by Feldberg & Guimaráis 
(1936). It was suggested by Brown & Feldberg (1936) 
that the nerve impulse was accompanied by a wave of 
propagated potassium ions which liberated ACh at the 
nerve terminals. A solution of Ringer -locke plus 
1.2% KC1 as described by Brown & Gray (1948) was diluted 
to a final concentration of 10-`. Injected into the 
skin this caused no sweating. The injection was 
repeated with higher concentrations up to 10 -2 which 
caused a mild stinging sensation without producing a sweat 
response. 
Effect of Nerve Block and Nerve Section on the ACh Response. 
The effects of procaine nerve block, preganglionic 
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sympathectomy and peripheral nerve section on the ACh 
threshold have been examined. Owing to the variable 
anatomical course of the cutaneous nerves to the fore- 
arm it is helpful to locate them with a weak faradic 
stimulus as described by Trotter & Davies (1909). The 
stimulus is applied to a series of points in e line 
across the flexor surface of the forearm about an inch 
below the elbow, the course of the nerves being revealed 
by a characteristic fluttering sensation in the extreme 
peripheral part of the area which will be rendered 
anaesthetic. Usually a medial and lateral branch are 
found at this level; sometimes a central branch is also 
present. 1 -2 cc. of a 4% solution of procaine contain- 
ing 1:200,000 adrenaline was injected subcutaneously 
near each nerve. In most cases at least one branch was 
successfully blocked in this way, as shown by anaesthesia 
and absence of reflex thermal sweating. The threshold 
concentration of mecholyl or ACh was determined simul- 
taneously in the anaesthetic area and on the opposite 
forearm in six subjects. (Table 15). In no case was 
there any significant difference. 
Repeated observations on a small series of cases 
subjected to upper dorsal sympathectomy (preganglionic) 
showed that there was no great change in the excitability 
Of the sweat glands by injected ACh (Table 16). Not all 
the limbs were followed over a period but eight examined 
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6 -12 months after operation, and showing a minimal or 
absent response to reflex heating, sweated after intra- 
dermal ACh in concentrations down to 10 -6. 
The effect of complete denervation was studied in 
a man who had suffered a lacerated wound of the left 
supra -trochlear region twelve months previously, the ulnar 
nerve being severed in two places. Cutaneous sensibil- 
ity and reflex sweating were absent in the distribution 
of the ulnar nerve in the forearm. The sweat glands in 
this area did not respond to ACh in concentrations up to 
1%. On the corresponding part of the opposite forearm, 
after procaine nerve block, there was a good response to 
10 -4 ACh. (Starch paper 20 ; 6.0 micro -amps.) and a 
profuse response to 10 -2 (Starch paper - over 100 : 18.0 
micro- amps.). 
It was reported by various workers, quoted by 
Langley (1922), that the sweat response to remote sub- 
cutaneous injection of pilocarpine in cats disappeared 
after denervation of the foot. On the other hand local 
local injection of 1% piloca.roine into the foot pad still 
caused sweating 42 days after section of the sciatic and 
popliteal nerves (Langley & Anderson, 1904). A response 
was also obtained in 4/6 animals 12 -38 days after 
cutting the sciatic or posterior tibial nerves (Langley 
1922). Hinsey c Cutting (1934) investigated the response 
to injection of pilocarpine into the foot pad. after 
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lumbar sympathectomy and found that it was unimpaired 
for periods up to several years. 
The advantages of local rather than remote sub- 
cutaneous or intravenous injection of test drugs have 
already been pointed out, and the reports from a number 
of sources (List & Peet, 1938c, Sch5rcher 1939, 
L. Guttmann 1940, Palmer 1947), that in human subjects 
the sweat glands become more or less refractory to remote 
subcutaneous injection of pilocarpine or mecholyl after 
sympathectomy will not be further discussed. Three 
papers have appeared on the response to intradermal 
injection of mecholyl and ACh after sympathectomy: 
1) Gurney & Bunnell (1942) reported that sweating still 
occurred after intradermal injection of 2.5 x 10 -6 
mecholyl in two subjects tested 10 days and one year 
after preganglionic sympathectomy. Skin biopsy showed 
no change in the appearance of the sweet glands compared 
with normal areas. 2) Kahn & Rothman (1942) investi- 
gated 10 subjects after post -ganglionic sympathectomy 
and found a diminished or absent response to ACh and 
mecholyl as early as 32 hours after operation, becoming 
consistently negative after a period of fluctuation 
lasting 2 -62 days. They reported similar results in 
cats. They found no morphological changes in the 
denervated glands on biopsy, confirming Adson, Craig & 
Brown (1935). 3) Janowitz & Grossman (1950) studied 
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9 subjects after post -ganglionic sympathectomy. In 
4 subjects the response to ACh (1:10 to 1:1000) 
disappeared 30, 38, 48 hrs., and 7 days after operation. 
The other 5 were tested between 3 days and 7 months 
after operation and showed no response. In 10 other 
subjects the local sweat response to hexadienol was lost 
after post -ganglionic sympathectomy. No phase of 
sensitisation to ACh was seen (Cannon, 1939). 
It is thus clear that neither procaine nerve block 
nor preganglionic nerve section affects the sensitivity 
of the sweat glands to ACh. The response does disappear 
after procedures which destroy the peripheral autonomic 
fibres. This is not to say that ACh stimulates the 
glands through the nerve endings, since the disappearance 
of the response does not always coincide with the degener- 
ation of the peripheral fibres but may be delayed for as 
long as two months after nerve section. The glands do 
not become atrophic, and retain their power of secretion 
in response to direct thermal stimulation (Saito, quoted 
by Kuno, 1934: Janowitz & Grossman, 1950). It is 
possible that denervation initiates a molecular rearrange- 
ment on the cell surface leading to disappearance of 
"specific receptor areas" as defined by Clark, (1933). 
This may be a reversal of the process by which sensitivity 
is acquired in embryo, since Armstrong (1935) has shown 
that the response of the Fundulus heart to ACh does not 
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appear until after the cells have received their 
innervation. 
Latency of the ACh Response. 
This was measured rather crudely by holding the 
exploring electrode over the site of injection and 
timing the interval between the injection and the first 
movement of the galvanometer. After intradermal injec- 
tion of a weak solution of ACh in the forearm there was 
a latent period of 30 - 60 seconds before sweating was 
detectable. This delay could be reduced to 10 seconds 
by increasing the concentration of ACh injected, which 
suggested that it was mainly due to diffusion of ACh 
between the site of injection and the sweat gland 
receptors. Very high concentrations of ACh (up to 10 -2) 
were then tried, and a larger volume of solution was 
injected (0.1 cc. instead of 0.01 cc.). To our surprise 
the latent period wes not further reduced. Several 
different subjects were tested but none was found in 
whom secretion was detectable within 10 seconds after 
injection. 
In contrast with this finding, nerve stimulation 
produced a fall of plantar skin resistance within 1 - 2 
seconds. (This result was obtained by electrical 
stimulation of the peripheral cut end of the lumbar 
sympathetic at operation in a human subject). Moreover, 
it was repeatedly noted that reflex sweating elicited by 
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e painful needle -prick appeared "almost instantaneously ". 
Accurate measurement of the latency of the psychogalvanic 
response has shown it to be of the order of 2 sec. 
(Carmichael et al., 1940a). The delay at the neuro- 
effector junction is 100 - 200 milli- seconds (Brown,1937). 
Further experiments were done in chloralosed cats 
with the assistance of Dr. F. Hobbiger. A similar 
difference in the latent period following nerve stimula- 
tion and local injection of ACh into the foot pad was 
found. Close intra- arterial injection of ACh (0.3 cc. 
of a'10 -2 solution into the anterior tibial artery) 
caused "almost immediate" muscular contractions, but 
sweating could not be detected until 8 - 10 seconds 
after injection. 
In an attempt to account for these observations e 
number of factors were considered: - 
a) The secretory portion of the sweat gland is surrounded 
by myoepithelium which probably helps to expel secretion. 
We are ignorant of the coordination and control of this 
myoepithelium (Richardson, 1949). During nerve stimu- 
lation contraction may perhaps be elicited by some 
mechanism other than the release of acetylcholine at the 
nerve- ending. After intradermal injection of a mixture 
of adrenaline and acetylcholine the latent period was 
found to be as long as after ACh alone. Similar results 
were obtained with mixtures of (1) histamine and ACh and 
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(2) potassium chloride and ACh. The myoepithelium 
of the mammary gland responds to posterior pituitary 
extracts (Turner & Cooper, 1941: Folley, 1947). 
Mixtures of oxytocin and vasopressin with ACh were 
therefore tested: there wes no appreciable. shortening 
of the latent period. From these negative results it 
is concluded that none of the substances mentioned is 
likely to be concerned in the transmission of nerve 
impulses to the myoepithelium of the sweet tubules. 
The possibility has not been excluded that the relatively 
prompt appearance of secretion after nerve stimulation 
is due to contraction of the myoepithelium. 
b) Injected ACh might have to cross some "barrier" in 
order to reach the site of liberation of transmitter. 
This might consist of a "cholinesterase filter" surround- 
ing the neuro- effector junction. Prior injection of 
TEPP did not reduce the latent period. A similar 
latency was noted with carbachol which is not affected 
by cholinesterase, as well as with mecholyl and pilo- 
carpine. 
c) The barrier might be the cell membrane itself, if 
the nerve endings were actually intraprotoplasmic. 
Various methods of increasing permeability were tried, 
including ischaemia by local pressure or tourniquet, 
prior injection of procaine or histamine and addition of 
hyaluronidase to the injected ACh solution. None of 
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these measures reduced the latent period below 10 sec. 
There is both histological and pharmacological evidence 
against the suggestion that the release of transmitter 
is intracellular. Hillarp (1946) describes the auto- 
nomic nerve - endings as "e nervous ground plexus directly 
superimposed on the effector cells and interwoven 
between them ", and denies the existence of intraproto- 
plasmic nerve endings. Cook (1926) showed that on the 
frog heart methylene blue had an atropine-like action 
when applied to the cell surface which disappeared when 
the dye had penetrated within the cells. Intracellular 
administration.of ACh in striated muscle does not 
elicit contraction (Gerard, 1946). Various drugs 
(Narcotics, HON, H28) injected into amoebae do not 
produce the characteristic actions which are readily 
elicited by application to the external surface (Hiller, 
1927: Brinley, 1928e'b). Clark (1933) has pointed out 
that the minimal effective dose of ACh for inhibition of 
the frog heart, if spread out in a monomolecular layer, 
would occupy only 1/6000 of the cell surface. He inter- 
preted this in favour of the concept of specialised 
receptor areas on the cell membrane and not as evidence 
for an intre- cellular site of action. 
d) Acetylcholine might be temporarily fixed at the site 
of injection by some physico -chemical process, such es 
adsorption or combination of the solvent with the hydro- 
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-philic ground substance described by Day (1948). 
This substance lies between the main fibrous components 
of loose connective tissue and combines with injected 
water to form an oedematous node (Ranvier °s Boule 
d'oedéme). It is not clear whether or not the hydro- 
philic property is due to hyaluronic acid: in any case, 
hyaluronidase does not abolish the latent period. 
e) Injected material might pass into the skin lymphatics 
(Hudack & McMaster 1933: McMaster 1942). When injected 
dyes are studied with a dissecting microscope very little 
of the material is found in the interstitial tissue, 
except after trauma or inflammation. Most of it 
invariably passes into the skin lymphatics. It is 
unlikely that this would delay the arrival of such a 
highly diffusible substance as ACh at the cell membrane 
by ten seconds. Moreover, local trauma, histamine etc. 
did not abolish the latent period. The delay after 
intradermal and intra- arterial injection was of the same 
order. 
Thus no entirely satisfactory explanation can be 
offered for the long latent period of the sweat response 
to intradermal ACh. Taken together with the lack of 
correlation between sensitivity to intradermal ACh and 
spontaneous tendency to sweat, it calls for caution in 




The sweat response to intradermal ACh was inhibited 
by atropine and potentiated by anticholinesterases. 
Axon reflex responses to ACh and nicotine are 
discussed. 
Mecholyl was 200 - 400 times more potent than ACh. 
The smallest effective concentration of ACh (ACh 
threshold) in 50 normal subjects varied from 10 -7 to 10 -2. 
No significant sex difference was found. Sensitivity 
tended to increase in summer. 'There was no correlation 
between sensitivity to ACh and spontaneous tendency to 
sweat, except in one subject with congenital absence of 
sweat glands. Differences in threshold are not due to 
skin cholinesterase variations. 
Intradermal injection of potassium chloride gave no 
sweat response. 
Procaine nerve -block and pre -ganglionic sympathec- 
tomy did not affect the response to ACh. No response 
was obtained 1 year after peripheral nerve section. 
This may be due to disappearance of specific receptor 
areas on the cell surface. 
The latency of the response to intradermal ACh 
greatly exceeded the delay after nerve stimulation in 
man and in the chloralosed cat. This latency could not 
be reduced experimentally to less than 8 - 10 seconds. 
Factors which may contribute to the delay are examined. 
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CHAPTER 111. 
ATROPINE AND ANTICHOLINESTERASES. 
QUANTITATIVE ASPECTS OF ATROPINE -ACh ANTAGONISM. 
Intravenous atropine. 
By giving atropine intravenously in repeated small 
doses it was possible to demonstrate a progressive rise 
of ACh threshold. In figs. 3 and 4 are set out the 
results of experiments on two subjects who were given a 
total of 2.4 mgm. of atropine sulphate by increments of 
0.3 mgm. intravenously at 5 min. intervals. The ACh 
threshold (forearm) was determined after each injection 
of atropine and the effect on spontaneous palmar sweating 
was also noted. It was found that spontaneous sweating 
was completely inhibited before the response to injected 
acetylcholine 10 -3 had disappeared. 
Intradermal atropine. 
Further experiments in which local injections of 
atropine were given will now be described. At first 
when atropine and ACh were injected simultaneously, no 
blocking effect could be demonstrated. By constructing 
decay curves (e.g. fig.5). I discovered that the effect 
of atropine was to shorten the response to acetylcholine. 
Atropine must therefore combine more slowly than ACh 
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with the sweat gland receptors. (This may well apply 
to other blocking agents such as TEA - see page29 ). 
Clark (1933) noted that atropine acted more slowly than 
ACh on the frog heart. In later experiments the atropine 
was injected first and 15 - 20 minutes was allowed 
before injecting ACh into the atropinised area. In this 
way the smallest concentration of atropine was found 
which would block the threshold concentration of ACh. 
This was compared with the blocking effect of different 
concentrations of atropine on thermal sweating induced 
by heating the feet (Table 17). 
At first sight it might appear possible to calculate, 
from the data in Table 17 and figs. 3 and 4, the concen- 
tration of ACh et the neuro- effector junction during 
thermal and palmar sweating. A moment's reflection will 
show that we should need to know (1) the amount to which 
the injected ACh is diluted by tissue fluid before making 
contact with the receptors: (2).the nature of the differ- 
ences between stimulation of the glands by nerve impulses 
and by local injection of ACh. These differences have 
been discussed in Chapter 11. The most that can be said 
is that in the subjects tested nervous activity had an 
effect equivalent to that produced by intradermal injec- 
tions of 10-3 to 10 
-4 
acetylcholine. 
An observation arising out of these experiments 
which I am at a loss to explain is the discrepancy between 
46. 
the dose - response curves of locally and intravenously 
administered atropine. In an idealised graph (Pig. 6) 
derived from all the available data on inhibition of 
thermal end palmar sweating there is a straight -line 
relationship between I.V. dose and log. local concentra- 
tion. This applies to other autonomic drugs as well. 
It is also clear from the fact that 1 mgm. of atropine 
I.V. will produce roughly the same inhibition as 10 -5 
locally that the drug is concentrated on the cell recep- 
tors (since 1 mgm. dissolved in the extracellular fluid 
or total body water would give a tissue concentration of 
less then 10 -7). Possibly conditions are more favour- 
able for uptake by the receptors when a drug is introduced 
into the blood stream. 
EXPERIMENTS WITH ANTICHOLINESTERASE DRUGS. 
Release of ACh by sweat nerve -endings. 
Since eserine and neostigmine potentiated the sweat 
response to injected ACh it was thought that infiltration 
of an area of skin with an anticholinesterase drug would 
reveal whether ACh was being released from the sweat nerve - 
endings a) with the subject at rest in a cool room, 
b) during the latent period of thermal sweating. A number 
of experiments were done with neostigmine 10 -4 before it 
was realised that this substance has a direct stimulating 
action on the sweat glands in high concentration (see p.50). 
In order to prove that the sweating is due to release of 
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ACh and not to a direct action it is necessary to show 
that it is prevented by procaine block of the cutaneous 
nerves. All the observations recorded in Table 18 
were made in winter at e room temperature of 18 - 20° C, 
spontaneous sweating being absent on the forearms. 
The completeness of the nerve block was subsequently 
tested by reflex heating. It can be seen that release 
of ACh at the nerve endings was occurring in several 
subjects. 
It happened that all these subjects were males. 
Five female subjects were tested in the absence of nerve 
block; none responded to neostigmine (10 
-6 
to 10 -4). 
Of four women who were tested with 10 -4 eserine three 
gave no response, and one sweated in July but not in 
March. The threshold concentrations of neostigmine in 
two men were 10 -6 and 10 -7. Eserine was used in another 
male subject and was effective in concentrations down to 
10 -6; there was no response to 10 -7. Since eserine has 
no direct stimulating action on the sweat glands (p. 50 ), 
this is further evidence that in a cool environment trans- 
mitter substance may be released from the nerve endings 
in amounts too small to stimulate the sweat glands. That 
the ACh is actually released as a result of nerve 
impulses and does not simply diffuse out of the nerve 
endings, is shown by the effect of nerve block. The 
possibility has to be considered that there are cholinergic 
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endings in the skin other than those supplying the sweat 
glands, from which the ACh might be released. The 
existence of cholinergic vasodilator fibres in muscle 
was demonstrated in the dog by Billbring & Burn (1935) 
but they found no positive evidence that such fibres 
were present in the skin (Bülbring & Burn, 1936b.) 
The release of ACh from the nerve -endings during 
the latent period of thermal sweating was observed in 
2 subjects (fig. 7). It begins about 10 minutes before 
detectable sweating appears in the untreated areas. The 
phasic variations characteristic of submaximal sweating 
(Randall, 1946) are well seen in the neostigmine record. 
No summation of liberated and injected ACh could be 
demonstrated. (Table 19). 
Measurement of skin cholinesterase. 
A preliminary approach was made to the problem of 
measuring the cholinesterase activity of the skin in situ. 
The effect of mixtures of ACh and eserine injected intra- 
dermally was compared with that of ACh alone, with the 
object of finding the smallest concentration of eserine 
needed to produce definite lowering of the ACh threshold. 
In four out of six subjects 10 -4 eserine was needed and 
in the other two 10 -5 eserine. These concentrations are 
unexpectedly high, and I suspect that eserine may combine 
more slowly than ACh with the enzyme (cf. atropine end TEA) 
so that it cannot easily prevent destruction of ACh when 
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injected simultaneously. Burgen (1949) found that in 
vitro eserine combined rather slowly with cholinesterase 
in the presence of substrate, requiring 10 min. to reach 
equilibrium. 
According to Krayer &others._ (1944), the concentra- 
tions of eserine required to produce 20¡o and 80% 
inhibition of serum cholinesterase in vitro are 10 -6 and 
10 -5 respectively. If the kinetics of inhibition are 
similar for the cholinesterase in vivo, one is working 
within a very narrow range. It would be difficult to 
a 
say whether /given degree of potentiation was due to 
partial inhibition of a high concentration of enzyme or 
complete inhibition of a low concentration of enzyme. 
As a measurement of cholinesterase activity the maximum 
potentiation by inhibitors is therefore to be preferred. 
The following technique would meet these objections: - 
(a) the cutaneous nerves should be blocked with 
procaine; 
(b) a potent, irreversible, cholinesterase inhibitor 
should be injected intradermally and allowed to 
act for 15 mins.; 
(c) the ACh threshold in the treated area should then 
be determined and compared with that of untreated 
skin. 
Effect of sympathectomy on skin cholinesterase. 
Brücke (1937) found that cholinesterase disappeared 
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from the sympathetic ganglia of cats after preganglionic 
nerve section. Preganglionic sympathectomy is not 
followed by disappearance of skin cholinesterase. 
One woman who had been operated on three months previously 
was subjected to reflex heating. There was no response 
on the sympathectomised arm. 0.1 cc. of a 10 -4 solution 
of the anti -cholinesterase Nu 683 (the dimethyl carbamic 
ester of 5- phenyl -2- hydroxy -benzyl- trimethylammonium 
bromide) wes injected intradermally. Twenty minutes 
later 0.01 cc. of 10 ACh was injected 5cm. away. After 
allowing time for the response to develop the electrical 
readings were a) at site of Nu 683 injection - 0, b) et 
site of ACh injection 0.8 micro- amps., c) half way 
between the two - 5.0 micro -amps. Starch paper readings 
corresponded. Hundredfold potentiation of the response 
to ACh by`èserine, tetreethylpyrophosphate and 
neostigmine was observed in two other subjects on several 
occasions between three and nine months after pregan- 
glionic sympathectomy. It has not been possible to study 
the skin cholinesterase by this technique after degener- 
ation of the postganglionic fibres since the glands no 
longer respond' to ACh (page:35 ). The question could be 
settled by skin biopsy and manometric estimation. 
Direct action of anticholinesterases on sweat glands. 
It is gëflerally believed that anticholinesterases 
act by competitive inhibition of the enzyme. If this 
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is so, they probably have certain structural features 
in common with acetylcholine and it would not be surpri- 
sing to find that they were also capable of combining 
with specific cell receptor groupings to produce direct 
stimulation of effector organs. This theme has been 
developed by Koelle & Gilman (1949). Riker & Wescoe 
(1946) showed that neostigmine had a direct action on 
striated muscle, and Hobbiger (1950) has demonstrated e 
direct effect on the frog rectus abdominis muscle. 
A direct stimulating action of neostigmine on sweat 
glands in high -concentration (10 -4) was, suggested by the 
finding that procaine nerve block did not prevent the 
response to intradermal injection. Further evidence 
was obtained by experiments on sympathectomised subjects, 
in whom neostigmine 10 -4 never failed to cause sweating, 
(Table 20.), although in three of the four subjects there 
was e negative response to high concentrations of other 
anticholinesterase drugs. In a concentration of 10 -4 
eserine, Nu 683 and Ro30340 (m-dimethÿlamino- phenyl- 
diethylphosphate- methyl -methylsulphate) had no direct 
action. Tetraethylpyrophosphate (TEPP) 10 -4 gave no 
response on one occasion and a small response on another: 
10-3 caused profuse sweating in two subjects. 
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SUMMARY. 
Data are presented on the quantitative aspects of 
inhibition by intravenous and intradermal atropine of 
a) spontaneous sweating, b) sweating produced by intra- 
dermal acetylcholine. 
In order to prevent the action of ACh by intradermal 
atropine, the atropine must be injected first and allowed 
to act for some minutes before the ACh is introduced. 
The effects of intravenous and intradermal atropine 
are compared. . 
By intradermal injection of low concentration of 
anticholinesterase drugs it was demonstrated that the 
release of ACh by the sweat nerve -endings begins some 
minutes before sweating can be detected when the subject 
is exposed to external heat. Release of ACh may occur 
in the absence of sweating even at quite low environ- 
mental temperatures (18 - 20 °C.). It ceases after 
procaine nerve block. 
Measurement of skin cholinesterase in situ is 
discussed. This does not diminish after preganglionic 
sympethectomy. The effect of true denervation of the 
sweat glands on the skin cholinesterase cannot be 




injected intradermally, stimulated sweat glands isolated 
by procaine nerve block or preganglionic sympathectomy. 
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Eserine, and certain other anticholinesterase drugs, 
had no such effect in concentrations up to 10 -4 . 
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CHAPTER 1V. 
THE RESPONSE TO ADRENALINE. 
Interest in the possible existence of an 
adrenergic component in the control of sweating has 
recently been revived by Haimovici (1948) who reported 
that intravenous dibenamine reduced palmer sweating in 
man. This was also briefly noted among the effects of 
dibenamine by Hecht and Anderson (1947) end by Medinets 
et al. (1948). It had long been known that in certain 
species e.g. the sheep and the horse, adrenaline injec- 
tions caused generalised sweating, (Kuno, 1934). Bacq 
(1932) reported local sweating with intradermal 
adrenaline in the horse. But since the pharmacological 
investigation of sweating by Langley, Burn, Dale, Feldberg 
and other was chiefly carried out on the cat, a species 
in which the sweat glands happen not to respond to 
adrenaline, the idee that ACh was the sole chemical 
transmitter became generally accepted. After the publi- 
cation of Heimovici's paper, Sonnenschein (1949) investi- 
gated the response of human sweat glands to intradermal 
adrenaline and reported positive results in 21/30 subjects. 
He got responses with concentrations as low es 10 -8 from 
the forearm skin. The response was said to be markedly 
inhibited by dibenamine and ergotamine but not by 
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atropine or TEA. (Sonnenschein et al., 1949). 
Kisin (1948) also reported stimulation of sweat glands 
by local injection of adrenaline. Sonnenschein's 
results were confirmed by Weds (1950), who found that 
80% of normal Japanese subjects aged 14 - 24 responded 
to 10-7 adrenaline and the rest to 10 -6. (He made the 
interesting observation that the sensitivity of the sweat 
glands to adrenaline was much less in children and old 
people. In children under 4 there was usually no 
response to 10 -4 adrenaline, except during the first week 
of life when excitability was about the same as in the 
mother. This led him to the conclusion that there was 
some hormone or humoral agent responsible for maintaining 
the excitability of the sweat glands). 
I confirmed that intradermal adrenaline does often 
stimulate the sweat glands in man and did a number of 
experiments to investigate the possible physiological 
significance of this observation. Inhibition of palmer 
sweating by intravenous dibenamine, a substance with 
powerful central effects, is of course unacceptable as 
evidence that adrenaline is actually concerned in the 
transmission of nerve impulses to the sweat glands. 
What is needed is the demonstration that spontaneous 
sweating can be inhibited, by local injection of a selec- 
tive adrenaline blocking agent. This presented unex- 
pected difficulties. Before describing these experiments 
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I wish to deal with one or two points about the 
adrenaline response. 
The effect is not due to release of acetylcholine 
by the adrenaline since it. is not prevented by atropine 
(Table 21). 
In Table 22 the smallest effective concentration 
of 1- adrenaline is compared with that of acetylcholine 
and. dl- noradrenaline. 10/12 subjects responded to 
adrenaline in concentrations of 10-3 to 10 -7. Allowing 
for the lower potency of the racemic preparation, the 
sensitivity to noradrenaline was the same as the adrenal- 
ine sensitivity in the six individuals tested. 
Noradrenaline was tried on the cat's foot pad but, like 
adrenaline it produced no response while ACh caused 
profuse sweating. It was suspected that the sensitivity 
to ACh might vary inversely with the adrenaline sensi- 
tivity but this was found not to be the case. It can 
be seen in Table 22 that the two run closely parallel, 
which disposes of the attractive hypothesis that in some 
individuals ACh, in others adrenaline is the principal 
transmitter to the sweat glands. 
The secretion of sweat after adrenaline is prolonged 
and has been detected more than an hour after the 
injection. It cannot therefore be due simply to stimu- 
lation of the myoepithelial elements since any sweat 
expressed in this way would evaporate in a few minutes. 
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The secretory response appears after a latent period 
of about thirty seconds. Obvious vasoconstriction 
takes longer to develop. When vasoconstriction is 
established the amount of sweat secreted becomes very 
small as judged by the size of the starch paper dots. 
This is comparable to the effect of obstructing the 
circulation on thermal sweating (Randall et al., 1948), 
and recalls the observation of Langley and Uyeno (1922) 
that the sweat response to pilocarpine on the cat's paw 
was attenuated by adrenaline. 
Ephedrine in a concentration of 3 x 10-3 was tried 
in two subjects who were sensitive to low concentrations 
of adrenaline. No sweat response was obtained.. This 
is consistent with the theory that ephedrine acts indir- 
ectly by inhibition of amine oxidase (Gaddum & Kwiatowski, 
1938), since it is proposed to show that no ádrenergic 
fibres supply the sweat glands. Moreover, potentiation 
of the sudomotor effect of adrenaline was not demonstrated. 
In considering adrenaline blocking agents suitable 
for injection into the skin dibenamine was at first 
rejected because of its necrotising property. The first 
compound tried was Dihydroergocornine (DHO). 0.05 cc. of 
a 10 -4 solution was injected intradermally at three sites 
on the forearm. 15 mins. later adrenaline 1Q 
-4 
gave no 
response when injected into the treated area, although 
the response from normal skin was very marked. 
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Unfortunately the response to 10 -4 ACh was also 
markedly inhibited. (Table 23). After reflex heating 
the treated areas sweated less than the controls. A 
second experiment was done in which weaker solutions of 
DHO were used. The response to 10 -6 adrenaline was 
completely inhibited by 10 -5 DHO and partially inhibited 
by 10 -6 DHO. 10-5 DHO did not diminish the response to 
10 -5 ACh (Table 24). After reflex heating the treated 
areas sweated equally with the control areas. It will 
be noted that compared with the first experiment the 
inhibition of 10 -4 adrenaline by 10 -4 DHO was less 
complete and that the depression of thermal sweating by 
DHO 10 -4 did not occur on this occasion. 
Since I felt that these results were inconclusive 
I tested á number of other compounds for their ability 
to block the adrenaline response selectively. The inhibi- 
tory effect of Dihydroergocristine (DOS) was, if anything, 
weaker than that of DHO (Table 25) . ïv,i - dibenzyl -beLa- 
chloroethylamine hydrochloride (dibenaminel 5 ¡o in alcohol 
propylene- glycol,was allowed to act for 5 mins. after 
injection of 0.05 cc. There was no inhibition of the 
response to 10 -5 adrenaline (Table 26). Various dilu- 
tions of this preparation in saline were also ineffective. 
(5% dibenamine was slightly painful on injection and a 
tender lump appeared later). Piperidyl methyl benzodioxane 
(933F) 10-3 X 0.1 cc. was also tried and had no inhibitory 
59. 
effect (Table 27). Finally 2- benzyl -imidazoline 
hydrochloride (Priscol) was tested: 3 mins. after 
injection of 10 -2 x 0.05 cc. the sweat response to 
adrenaline 10-3 was almost completely absent (Starch 4 
compared with over 100), and there was no vasoconstriction.. 
Later the blocking effect was demonstrated in another 
subject. (Table 28). Thermal sweating was enhanced by 
Priscol 10 -2, probably owing to the vasodilator effect. 
There is therefore no evidence from experiments 
with DHO and Priscol for an adrenergic component in 
thermal sweating. Another line of evidence is the effect 
of atropine. It is easy to show that atropine totally 
suppresses sweating due to reflex heating in concentra- 
tions as low as 10 -6. In the subject shown in fig. 8, 
who happened to be a West Indian, the contrast between 
sweating and non -sweating areas after dusting with 
Quinizarine powder. is not very good, but it can be seen 
that the atropine -treated areas are dry while the DHO 
areas sweat equally with the controls. No electrical 
reading was obtained over the atropinised areas, the 
controls reading 4 - 8 micro -amps. Total suppression 
of thermal sweating by oral, intravenous -and local 
atropine has been observed on many occasions in different 
subjects. since the response to adrenaline is riot 
inhibited by atropine, it is concluded that the only 
transmitter involved in thermal sweating is acetylcholine. 
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Emotional sweating was separately investigated. 
It is significant that although palmar sweating was 
usually inhibited by intravenous 1)ibenamine, it was not 
abolished in those subjects who vomited (Haimovici, 1950). 
This strongly suggests that any inhibitory effect is due 
to a central action. Although it is not true, as 
Sonnenschein et el. (1949) suggest, that the palmar sweat 
glands cannot be stimulated by local injection of adrenal- 
ine (Table 29); there is no evidence that adrenaline is 
concerned in the transmission of impulses to these glands. 
In five normal subjects atropine 5 X 10 -4 was introduced 
into the palm by iontophoresis (1 - 2 M A /Cm2 for 10 mins.). 
Spontaneous sweating was completely suppressed in every 
case. Similar introduction of DHO had no such effect. 
Mental arithmetic and sudden loud noises increased sweat- 
ing in the control and DHO areas but no sweating appeared 
on the atropinised area. A similar result was obtained 
from the plantar sweat glands in a case of hyperhidrosis. 
Another hyperhidrotic subject was studied after suppresion 
of spontaneous sweating by procaine block of the median 
nerve at the wrist (Table 30). Atropine 10 -5 (0.02 cc.) 
and DHO 10 -5 (0.02 cc.) were each injected at two sites 
on the anaesthetic palm. There was no response to 10 
ACh in the atropinised skin; adrenaline 10 -4 gave a 
marked response. Before the DHO area could be similarly 
tested the nerve block wore off and sweating returned, 
61. 
reaching control levels on the DHO areas although the 
second atropine area remained dry. The excessive 
sweating was relieved in this case by small doses of 
atropine by mouth. 
These observations prove that adrenergic nerves are 
not concerned in, thermal and emotional sweating. It is 
perhaps surprising that glands which are capable of res- 
ponding to adrenaline should not be stimulated by local 
diffusion of transmitter from closely adjacent vaso- 
constrictor terminals. Hillarp (1949) partially dener- 
vated salivary glands, then studied them histologically 
after prolonged nerve stimulation. He found highly 
active cell complexes (as judged by their granule and 
vacuole content) side by side with relatively inactive 
acini. This sharp localisation of transmitter at choli- 
nergie endings may be achieved by a high concentration of 
cholinesterase, but since the enzymatic inactivation of 
adrenaline is relatively slow it seems likely that local 
diffusion of transmitter is limited by some other mechanism. 
The work of Armstrong (1955) on the Fundulus heart 
showed that sensitivity to ACh is only acquired by cells 
after they have received their innervation. The develop- 
ment of sensitivity is probably associated with the 
appearance of specific receptor areas at those points on 
the cell surface with which the nerve terminals make 
contact. It seems unlikely that sensitivity to adrenal- 
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line is acquired in this way. However denervation of 
the sweat glands results in loss of the response to 
adrenaline and noradrenaline as well as to acetylcholine 
(Janowitz & Grossman, 1950). 
The possibility that circulating adrenaline might 
sometimes cause sweating was next examined. A subject 
who responded to 10 
-7 
adrenaline intradermally was given 
an intravenous infusion of adrenaline by a constant 
speed infusion apparatus. Ascorbic acid was added to 
the solution to delay oxidation. The rate of infusion 
was 10 microgrammes /min. for the first 7 mins. then 
15 microgrammes /min. for 3 mins. Although pallor, 
transient tachycardia and an increased pulse pressure 
were noted there was no increase of sweating on the palms, 
forearms or forehead. This was perhaps not surprising 
in view of the difficulty of stimulating the sweat glands 
with intravenous infusions of ACh and mecholyl. Intra- 
arterial injection of adrenaline was then tried in the 
same subject, 20 microgrammes in 2 cc. being rapidly 
injected into the brachial artery. Blanching of the 
hand developed 1 - 2 minutes after the injection end there 
were just appreciable systemic effects. The skin 
resistance was measured at marked sites on the forearms, 
palms end fingertips (Table 31). After the injection 
there was a transient fell of resistance on both forearms 
except the area previously treated with atropine (10 -5, 
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0.1 cc. 20 mins. before). This was attributed to a 
sensory reflex effect. There was no significant change 
in the readings from the palms and fingertips. The 
readings which appeared on the atropinised areas after 
the injection continued to increase while readings on 
other sites were falling, and must have been due to the 
gradual disappearance of atropine from the skin. Intra- 
arterial injection was repeated in another subject whose 
sweat glands responded to 10 -5 adrenaline intradermally. 
It was confirmed that this local response was not blocked 
by atropine. 18 microgrammes of adrenaline were inject- 
ed into the brachial artery, producing coldness and marked 
pallor of the forearm and hand, with diminution of the 
radial pulse and slight systemic effects. Pilomotor 
stimulation was obvious. There was no increase of sweat- 
ing on the control areas, and two sites which had previous- 
ly been treated with atropine remained dry. 
It was therefore impossible to demonstrate stimu- 
lation of the sweat glands in man by intravenous or intra- 
arterial injection of adrenaline even in individuals who 
were highly sensitive to the sudomotor effect of local 
adrenaline injections. The two situations where adren- 
aline (or noradrenaline) sweating might occur spontane- 
ously are a) in cases of phaeochromocytoma where sweating 
is sometimes a feature of the attacks: b) in hypogly- 
caemia. I have not had an opportunity to investigate 
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a proved case of phaeochromocytoma. A 50 year old man, 
with diabetes and sustained hypertension, suffered from 
attacks of sweating with abdominal discomfort, rise of 
blood pressure, lacrimation, salivation and parotid 
swellings, the provisional diagnosis being diencephalic 
autonomic epilepsy. The sweating was found to be inhibi- 
ted by local injection of atropine. He discharged him- 
self before the effect of intravenous benzodioxane (933 F) 
on the hypertension (Goldenberg et.el., 1947) could be 
tried. Several other hypertensive patients have been 
tested with this substance butaso far none has shown a 
fall of B.P. and no tumour has been found in those subjec- 
ted to laparotomy. With the .development of methods for 
the estimation of adrenaline and noradrenaline in the 
E/ urine (Lúnd,1950, V. Juler,1950), it should become easier 
to detect cases of phaeochromocytoma. 
Profuse sweating often occurs during insulin hypo- 
glycaemia. Through the kindness of Mrs. Doniach of the 
Courtauld Institute of Biochemistry I was able to show 
that this type of sweating is inhibited by local injection 
of atropine. This means that it is due to cholinergic 
nerve impulses and not to circulating adrenaline. 
See also Engel A. & von Euler U.S.(1950),Lancet,2,387. 
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SUMMARY. 
Adrenaline and noradrenaline stimulated the 
sweat glands in man (but not in cats) when injected 
intradermally. The response was not inhibited by 
atropine. Individual sensitivity to ACh, adrenaline 
and noradrenaline was of the same order. 
There was no response to ephedrine. 
Prior intradermal injection of Priscol or 
hydrogenated ergot derivatives inhibited the adrenaline 
response. Benzodioxane (933F) and Dibenamine did not. 
Thermal and emotional sweating was completely 
inhibited by atropine in normal and hyperhidrotic 
subjects. Dihydroergocornine and Priscol had no such 
effect. It is concluded that the sweat glands have 
no adrenergic innervation. 
Intravenous and intra- arterial adrenaline failed 
to cause sweating in subjects who responded well to 
intradermal adrenaline. 
Profuse sweating during insulin hypoglycaemia was 
abolished by atropine and was therefore not due to 
circulating adrenaline. 
Circulating adrenaline or noradrenaline might be 




There are several clinical conditions of which 
hyperhidrosis is ,a feature. A case of probable 
diencephalic autonomic epilepsy (Penfield 1929) with 
paroxysms of sweating has already been mentioned. A 
rather similar case, in which disturbances of temperature 
regulation also occurred, showed the radiological 
features of agenesis of the corpus cailosum, a diagnosis 
which was later confirmed at post -mortem. Drenching 
sweats may occur in paraplegics (Heed & Riddoch 1917: 
Richter & Shaw, 1930: List & Pimente, 1944), due to a 
spinal reflex initiated by nociceptive stimuli or visceral 
distension. 
A case of unilateral frontal hyperhidrosis was 
described by Tarlov & Herz (1947). The disturbance was 
precipitated by unpleasant thoughts or excitement. In 
two such cases seen by us, the sweat response to thermal 
stimulation was also excessive on the affected area. 
Another curious variety of hyperhidrosis occurs on 
the face and head in response to the presence of food 
in the mouth (Haxton, 19488). Any highly flavoured 
substance may elicit the response, especially acid 
material such as apple and vinegar. Haxton calls the 
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syndrome "Gustatory Hyperhidrosis" and points out that 
the response normally occurs only after eating spicy 
food, like curry. Some individuals have an idiosyncrasy 
to chocolate - Claude Bernard for one - and others sweat 
after eating cheese or marmalade. (This must be the 
explanation of the "marmalade steamers" Commander Campbell 
used to describe on the Brains Trust). An excessive 
response has been described in syringomyelia and encepha- 
litis, after suppurative parotitis or injuries to the 
parotid region (auriculo- temporal syndrome) and after 
division of the cervical sympathetic. In the auriculo- 
temporal syndrome flushing and sweating occur in the pre - 
auricular region in response to the presence of food in 
the mouth. Uprus and co- workers (1934) attributed it to 
abnormal regeneration following nerve injury, and compared 
it with the "crocodile tears" seen after facial nerve 
lesions. But Langenskiold (1946) claimed that the glands 
on the affected side had been sensitised to ACh. 
Gustatory hyperhidrosis after cervical sympathectomy 
is not uncommon. (13 out of 36 cases in Haxton's series). 
Several workers have reported that there is an excessive 
response to local injection of parasympathomimetic drugs 
on the affected side (Haxton, l948a; Wilson, 1936; List & 
Peet, 1938d). It has been suggested that the sensitised 
glands might be stimulated by ACh diffusing from the 
salivary nerve -endings. This would hardly account for 
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sweating on the forehead. Wilson (1936) described a 
case (case 3 in his series), in which, after removal of 
the superior cervical ganglion, the glands on the fore- 
head responded to gustatory but not to reflex thermal 
stimulation. The sweating was completely abolished by 
atropine and by supraorbital nerve block. Unless one 
postulates diffusion from cholinergic vasodilator or 
motor nerve endings, the only possible conclusion is that 
these glands had a double nerve supply a) through the 
cervical sympathetic, transmitting impulses from the 
thermo- regulatory centre; b) through the fifth nerve. 
Since Wilson's patient had had the sensory root of the 
fifth nerve divided as well as having the superior 
cervical ganglion removed these accessory fibres after 
leaving the brain stem must have an independent course 
before joining the 5th nerve distal to the sensory root. 
They had no connection with the thermal sweat centre. 
Cause of essential hyperhidrosis. 
The investigations to be described have been confined 
to the condition known as "essential hyperhidrosis" 
(Haxton, 1948b: Boyd & Jepson, 1950) in which the excess- 
ive sweating occurs on the palms and soles, i.e. those 
areas responding to emotional rather than thermal stimuli. 
Several of our patients also had acrocyanosis - cold, 
blue, puffy hands and feet. The association of cold 
sweaty extremities with anxiety is well known (Wood, 1941), 
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end at first sight there appears to be a strong presump- 
tion that the cause lies in the central nervous system 
rather than at the periphery. But it would be quite 
easy to match a group of hyperhidrotic subjects with e 
normally sweating control group in which the incidence 
of psychological, disorders was identical - e point often 
overlooked in considering "psychosomatic" diseases. 
Nor can the fact that the hyperhidrosis is abolished by 
sleep and thiopentone narcosis (Boyd & Jepson, 1950) be 
accepted as proof that no peripheral abnormality is 
present. 
I examined the sensitivity of the palmar sweat 
glands to locally injected acetylcholine in 6 subjects 
with hyperhidrosis and 8 normal controls in whom the 
median nerve had been blocked at the wrist with 4% 
procaine. The ACh threshold varied over a wide range 
in both groups, from 10 -4 to 10 
-8 
in the byperhidròtic 
subjects and from 10-3' to 10 -8 in the controls (Table 32). 
This seemed to exclude an increased excitability of the 
glands as a cause of the abnormality. Later it occurred 
to me that the "threshold" sensitivity might be misleading 
and that the slope of the dose -response curve might be 
different in the two groups. I therefore re- examined 
my results end found that though the data on this point 
were incomplete, at least two of the control subjects 
had over 60 glands in action after the injection of 
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10 -5 ACh, e greater number than was seen in any of the 
abnormal subjects with this concentration. 
Possible mechanisms of autonomic overactivity may 
be tabulated as follows:- 
1. Nervous - a. Central. 
b. Ganglionic. 
c. Nerve- ending (Excessive release of 
transmitter). 
2. Local deficiency of cholinesterase. 
3. Hypersensitivity of tissue receptors. 
It is considered that the results quoted above 
exclude mechanisms 2 and 3 in the case of hyperhidrosis. 
The one peripheral abnormality which has not been ruled 
out is excessive release of ACh by the nerve - endings 
Electrical stimulation of the peripheral cut end 
of the lumbar sympathetic chain was tried in one case 
of thrombo -angiitis obliterans at operation. Sweating 
and vasoconstriction of the foot were obtained with 
8 volts at 25 /sec. It would be practicable to implant 
an electrode for 24 hours, so as to allow time for 
recovery from the anaesthetic before measuring the 
response. Knowing the sensitivity öf the sweat glands 
to ACh and the magnitude of the response to a given 
stimulus in hyperhidrotic and control groups, it should 
be possible to say whether there is an excessive release 
of transmitter in hyperhidrosis. Alternatively, if 
local injection of ACh is not accepted as a valid method 
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of testing the "sensitivity" of the glands (see p.42), 
the nerve stimulation technique would give information 
about the peripheral mechanism as a whole. 
The treatment of choice in severe cases of essential 
hyperhidrosis is sympathectomy (Roberts, 1934: Adson, 
Craig & Brown, 1935: Telford, 1938: Palmer, 1947: 
Hexton, 1948b). There is no tendency to clinical 
relapse as in Raynaud's disease, although some return 
of sweet function eventually occurs (Barcroft & Hamilton 
1948a,13). Presumably the new nerve pathway is 
functionally less efficient than the old (Neumann et al., 
1943). 
The non -surgical management of hyperhidrosis 
consists in the local use of formalin solutions and 
astringent lotions, irradiation (which is condemned by 
most authorities), and the administration of atropine 
by mouth. Since atropine only inhibits sweating in 
doses which also inhibit other secretions (Table 33) it 
is poorly tolerated by most patients. Moreover, 
atropine does not block the adrenergic impulses respons- 
ible for the concomitant acrocyanosis, where this is 
present. Recently Grimson and co- workers (1950) have 
reported the successful treatment of hyperhidrosis with 
the new paresympatholytic drug bete- diethyleminoethyl 
xanthene -9- carboxylate methobromide (banthine). Side 
effects included dilatation of the pupil, dryness of the 
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mouth and constipation. 
Theoretically,e ganglionic blocking agent should 
be particularly useful in the acrocyanosis- hyperhidrosis 
syndrome since it would inhibit both adrenergic and 
cholinergic nerve impulses. Until recently the only 
compounds available have been the quaternary ammonium 
salts. Apart from postural hypotension, these 
substances produced other unpleasant effects, such as 
sensations of coldness and prickling in the hands and 
feet and loss of visual accommodation; they may cause 
curariform paralysis (Graham, 1950); and their duration 
of action is short. Pentamethonium (C.5) and hexame- 
thonium (C6) salts produce a longer -lasting ganglionic 
blockade with fewer side effects (Paton & Zaimis, 19488,13ß 
Burt & Graham, 1950). Provided these drugs will inhibit, 
sweating without causing postural hypotension, they should 
prove useful in the control of hyperhidrosis. Smith(1950) 
reported that 06 in doses of 500 mgm. orally B.D. reduced 
acid secretion and gastric motility in cases of peptic 
ulcer but produced serious cardiovascular effects in 2/3 
of subjects. Paton (1950) suggested that this type of 
ganglionic blocking agent might be more effective in 
states of of abnormally high activity of the autonomic 
ganglia: thus, in hyperhidrotic subjects, the sweat nerve 
pathway might be more easily blocked than, say, the 
splanchnic vasoconstrictor pathway. 
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Observations have been made with intravenous 
pentamethonium bromide in 4 ceses of hyperhidrosis and 
in one normal subject. All were females. The results 
are shown in Tables 34 -37 and Fìg.9. Two injections 
of 10 mgm. each were given with an interval of 10 - 15 
minutes between, them. After the second injection 
postural faintness occurred in only one subject (A.E. 
Table 38) and was over while depression of sweating was 
still maximal. A definite effect on sweating was 
apparent after the first 10 mgm. in this case; in the 
others (including the normal control) it was doubtful 
with 10 mgm. but definite with 20 mgm. There was a 
tendency for the feet to be more affected than the hands 
(Fig. 9), a point also noted by Burt & Graham. Vaso- 
dilatation in the hands and feet accompanied the inhibi- 
tion of sweating in most cases. Well marked vasoconstric- 
tion developed in the hands in the normal control (Table 
34). Unfortunately the feet were not examined in this 
subject, but it is reasonable to assume that the vaso- 
constriction in the hands was a compensatory phenomenon 
accompanying vasodilatation in the lower limb, the ganglia 
of the upper limb continuing to transmit impulses from 
the vasomotor centre after those of the lower limb had 
ceased to function. In one subject (A.E. Table 36) there 
was a greater effect on the right hand and foot than on 
the left. 
74. 
These results show that it is possible to inhibit 
sweating with intravenous pentamethonium without 
producing unpleasant side effects. It was therefore 
decided to try pentamethonium bromide by mouth in the 
four hyperhidrotic subjects. The drug is dispensed in 
the form of syrup, since it is too hygroscopic to make 
e satisfactory tablet. The initial dose was 50 - 100 mgm. 
B.D. In two subjects (T.S. end G.S.) satisfactory 
clinical results were obtained with 150 mgm. B.D. A 
third subject (A.E.) required 250 mgm. B.D. and is now 
taking tablets of hexamethonium bromide in the same dose 
with good effect. The oral dose cannot be predicted from 
the response to intravenous pentamethonium, since subject 
A.E. was particularly sensitive to the effects of the 
drug in the preliminary (I.-V.) test. No side effects 
were noted in these three patients. Suppression of 
sweating end of vasoconstriction tended to be more complete 
in the feet than in the hands. The fourth subject (S.0.) 
complained of headaches when taking 150 mgm. B.D. As 
she was a frequent sufferer from headache an inert 
mixture was substituted without her knowledge. The head- 
aches persisted. 
The total period of observation in these ceses is 
still only 4 - 6 weeks. A longer period will have to 
elapse, and more cases will have to be studied, before 





The clinical varieties of hyperhidrosis are 
reviewed. 
Possible mechanisms of essential hyperhidrosis 
are discussed. The palmar sweat glands were not 
hypersensitive to intradermal ACh in six hyperhidrotic 
subjects as compared with a control group. More 
complete information about the peripheral mechanism 
could be obtained by nerve -stimulation experiments. 
The treatment of hyperhidrosis is considered, 
with special reference to the use of methonium 
compounds. Promising results have been obtained in 




Detailed summaries are provided et the end of 
each chapter. The main conclusions are given below. 
1) The sensitivity of sweat glands to intradermally 
injected acetylcholine (ACh) does not correlate well 
with spontaneous tendency to sweat. 
2) Sensitivity to ACh is lost after degeneration of the 
post- ganglionic nerve fibre. Preganglionic sympath- 
ectomy does not affect the response. 
3) After intradermal injections of ACh there is an 
unexplained delay of not less than 10 seconds before 
sweating is detectable. 
4) When injected intradermally atropine is taken up 
by the receptors more slowly than ACh. This relation- 
ship also applies to the inhibition of the action of 
nicotine by tetraethylammonium bromide. 
5) Release of ACh by the sweat nerve endings during 
reflex heating can be detected some minutes before 
sweating occurs. It may also occur in the absence of 
sweating at quite low environmental temperatures (18 - 
20 °C.). 
6) In most persons intradermal adrenaline can also 
stimulate sweat secretion, although there is evidence 
from experiments with blocking agents that the inner- 
vation of the sweat glands is purely cholinergic. 
77. 
7) There is no evidence that in hyperhidrotic subjects 
the overactive palmar sweet glands are hyper - sensitive 
to ACh. 
8) Oral administration of ganglionic blocking agents 
of the methonium group is a promising method of 
treatment in hyperhidrosis. 
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- - 6 0.4 
Deep intra- 
dermal 20 1.5 6 0.4 
Subcutaneous 26 2.2 6 0.6 
Intramuscular. 0 0 - - 
In this table and in subsequent tables the words - 
Starch paper = number of dots on starch paper applied 
to iodine -treated skin. 
Micro -amps = amount of current passing through skin. 
and the symbols - 
0 = No response. 
- = No observation. 
Except where otherwise stated injections were made into 
the flexor surface of the forearm. 
Table 2. SUBJECT A.C.P. 
RESPONSES TO INTRADERMAL MECHOLYL 10-3 (0.016c) INJECTED 














1 37 h.0 3 0.3 
5 - 7.0 - 0.8 
7 - 11.5 - 1.0 
7_ - 8.5 27 2.2 
30 - 7.0 - 2.h 
L12 - 1.2 1.0 
50 0 0.3 0 0.2 
62 - 0 - 0 
1-- 
2 0 h.0 22 0.9 
6 - 8.8 - 2.h 
10 _ 12.0 - 3.2 
a - 8.2 - 6.1 
36 - 11.0 - 3.0 
WI - 3.4 - 2.2 
56 0 0.7 0 0.7 
1_ 
Table 3. RESPONSES TO INTRADERMAL ACh. ON THE TWO FOREARMS. 
SUBJECT INJECTION 









R. B. R. R. ACh.. 10-5 0 0. 1 0 0 
10-4 0 0 0 0 
10-3 2 0.9 10 1.8 
J.K. ACh.10-7 0 0 0 0 
10-5 0 0.h 0 0. 05 
10-4 19 1.7 11 1.4 
J.A.F. ACh.10-5 0 0 0 0 
10-3 0 0 0 0 
5x10-3 - 0 - 0.8 
L1x10-3 - 2.0 - 0, 1 
3x10-3 - 0.5 - 1.5 
2x10-3 - 0.LG - 0 
10-2 47 1.7 37 3.0 
-- 
N.W.F.H. ACh.10 0 O.3 0 0.1 
10 0 0.6 0 0.1 
10-3 27 1.6 3h . 2.7 
A. C. P. ACh. 10-7 0 0 0 0 
! 10-5 o o o o 
10-4 2 0.05 0 0 
10-3 23 3.8 5 0.7 
I. G. H. ACh. 10-7 - 0.1 - 0.1 
10 J - 0.1 - 0.1 
10-4 - 0.2 - 0.2 
10 2 - 0.7 - 0.9 
10- - 3.0 - 3.0 
Table Li. COMPARISON OF ACh THRESHOLDS ON PALM _'ND FOREARM. 
SUBJECT PALM FOREARM 
I. S. 10-7 10-5 
A.C.P. 10-4 10-5 
A.A.G.L. 10-5 10-5 
G. du. B. 10-5 10-4 
J. R. 7.0-7 10-5 
B. P. S. 10-8 10-6 
G. Y. B. 10-7 10-6 
J. A. F. 10-7 ]0-5 
I.C,.H 1O-3 10-3 
. 
B.F. 10-L 10 
5 
S. C. 10-6 10-5 
G. L. S. 10-7 10-5 
G.R. S. 10-5 10-5 
T. Y. C. 10-8 10-7 
ACh threshold = smallest effective concentration 
of intradermally injected Acetylcholine 
which produced me ating. 
Table 5. SUBJECT T.M.C. COMPARISON OF DILUTIONS OF ACh. 
PREPARED a) with a series of syringes, 
b) with a series of pipettes and 
flasks, 












micro -amps. STARCH 
PAPER 





2 - 1.1 - 0.5 0.1 
4 6 1.2 -- 0.8 
6 - 1.0 - 1.0 
9 - - 2 0.8 
14 - 0.1 - - 
10 -10 2 - 0.2 - 0.1 0.1 - o.2 
5 - 0.2 - 0.1 0.1 - 0.2 
Table 6. COMPARISON OF IODINE-STARGH PAPER AND 
ELECTRICAL READINGS AFTER iNTRADD.WAL 
INJECTIONS OF ACh ,IECHOLYL AND ADRENALINE 
SUBJECT ! STIkULUS 
' 
STARCH PAPER 




ACh 10 -5 0 0 
R. V. S. 10-4 8 1.6 - 
10 -3 15 2.0 
A 
ACh 10'6 0 0 
W.R. 10-5 3 0.2 - 
10 -4 11 1.0 
&ECHOLYL 10 -7 0 0.2 
lo-6 2 0.5 
A.C.P. - 
10 -5 7 0.7 
(REPEAT) 10-5 9 1.0 
ADRENALINE 
10 -6 0 0 ABSENT 
10-5 0 0 ABSENT 
M.K.M. Later 0 0.6 JUST VISIBLE 
10 
-4 
3 0.5 ABSENT 
Later 1 4.0 MARKED 
10 -3 10 2.0 SLIGHT 
Later 0 8.0 MARKED 
Table 7. Subject J.K. 
EFFECT OF INTRAVENOUS ATROPINE (0.5 + 0.5 mg.) 













Nil 10 -10 1 0.3 
10 -9 6 1.8 1.2 - 1.45 
10 -8 5 2.2 
0.5 mgm. 10 
-10 
- 0.1 1.25 
10 -9 3 0.8 




10 -5 12 2.2 
Saliva was collected by expectoration in 4 - minute 
periods. An interval of 3 minutes was allowed 
between successive collection periods. 
Table 8. SUBJECT W.F.F. 
EFFECT OF ATROPINE ON RESPONSE TO INTRkDERMAL ACh. 




5.18 p.m INJECTION INJECTION - 
5.19 0 7.8 o 
5.20 0 10.0 0 
5.25 0 5.4 0 
5.33 0 0.9 o 
Atropine Sulphate 6 x 1O 
-2 
introduced into skin 
by iontophoreeis (1 MA /SQ. CM /10 mins.) at 5.00 
p.m. At 5.18 p.m. injection of ACh 10-a x 
0.01 ml. 
Table 9. Subject I.S. 
EFFECT OF 10-3 TETRAETHYLPYROPHOSPHATE 
(T E P S S TTRA- 
S.EMIT.Âr ACh. 
INJECTION 









ACh 10 -7 4 0.5 - - 
10 
-6 
13 1.2 0 0 
10 -5 - - 3 0.2 
10 -4 - - 11 1.0 
0.1 cc. TEPP was injected 5 mins. before the 
injection of ACh. 




AGED 16 -25 




J.K. 10-5 10-9 
_g 
N. F. hj. H. 10- 10 ' 
J.K.L. 10-5 10-7 
D.L.C, 10-5 10-8 
I. G.1-1. 1.0- J 10 -7 
A. C. P. 10--- ' 10-5 
A. m. 
-4 10 -6 10 
G.E.M. 10-3 10 5 
M. 0.11i. 10-4 10-Z 




A. M. E. 10-J 10-5 
M. S. G. 10_!{ 10-4 
Table 11. 
DISTRIBUTION OF Ach THÏ SHOLDS (FOREARMLI 









10-7 1 0 1 
10-6 3 2 5 
10-5 11 8 19 
10-4 6 7 13 
10-3 4 6 10 
lo-2 o 1 1 
No response 
to 10-2 
0 1 1 
Table 12. 
EFFECT OF HYALURONIDASE ('HYALASE') ON 
'1 .; `S _ i _i ACh. 
SUBJECT INJECTION 










M.K.M. ACh 10 -6 0 0 0 O 
10 -5 0 0.4 20 6.0 
10 -4 20 4.0 .- - 
M.K.M.2 ACh 10 7 0 0 0 0 
10 -5 1 0.8 25 9.0 
.J.P.3 ACh 10-6 0 0 0 0 
10 -5 1 0.5 22 6.0 
f 
10 -4 12 1.8 - - 
1 = 'Hyalase' & ACh injected simultaneously 
2,3 = 'Hyalase' injected 5 - 10 mins. before ACh. 
























10 -5 10 -5 10-5 
10-3 
10-3 
a) 1949 January. 
b) 1949. November. 
Table 1L. EFFECT OF INTRADERMAL NICOTINE ON 
SWEAT GLANDS. BLOCKING BY IN`i'RA- 
DERMAL TETRAETHYLA.MMONIUM BROMIDE. 
Ï SUBJECT INJEC"l'ION STARCH 
PAPER 
.,u:z 
G. du B. P 10-5 x 0.01 cc. - 0 
10-4 x 0.01 - 0 
10-5x0.05 - 0 
10-5 x 0.10 - 0 
10-5 x 0.15 - 0 
J.H. A. 10-5 x 0.05 over 100 20 
B. 10-5 x 0.05 0 005 
A = before T. E. A. B. 
B = 8 mins. after intradermal injection of 
0.15 cc. of T. E. A . B. 10-2 
Table 15. 




EFFECT OR PROCAINE NERVE BLOCK ON 
SENSITIVITY TO INTRADERMAL MECHOLYL & ACh. 
SUBJECT NORMAL SKIN ANAESTHETISEI.) SKIN- 
A.C.P. 10- 10 
-6 
I.G.H. 10-7 10-7 
D.L.C. 10-8 10-9 
J.A.F. 10-3 10-3 





Cutaneous nerves to the forearm located below 
the elbow by faradism and blocked with 4% 
procaine. Completeness of block tested 
by reflex heating. 
Table 16. EFFECT OF PREGANGLIONIC SYMPATHECTOMY 
ON ACh. THRESHOLD IN FOREARM. 
(6 LIMBS IN 5 SUBJECTS) 
SUBJECT BEFORE 
OPERATION 
5 - 14 days 
after 
operation. 



































H.M. - - - 10 -3 
J.Sch. - 10 
-li 
- - 
21E11:112_17.1. BLOCKING EFFECT OF INTRADERTVlAL ATROPINE 
ON SWEATING INDUCED BY LOCAL INJECTION 
OF ACh AND BY BELIE( HEATING 
SUBJECT NATURE 
OF 






10-7 10_6 10-5 10-4 
C.M. ACh 10-5 0 
104 1.2 0.7 0.8 0.8 0.1 
HEATING 0.4. - 2.0 0.9 1.0 0.8 0.2 
G.du B. ACh 10-3 6.0 7.0 0 0 0 
BEATING 3.0 - 6.0 3.0 3.0 1.0 0.6 
J.F. Ach 10-5 0 - - - - 
10-4 1.2 1.0 0.4. 1.0 0 
WEATTIV G 3.0 - 6.0 3.0 1.5 1.2 0.1 
B.A.S. ACH Not tested 
HEATING 2.0 2.0 1.2 0 0 
Table 18 FECT OF PROCAINE NERVE BLOCK Oh THE 
.RESPONSE TO fl RADEPLAL NEOSTIGWil \TE 





SWEAT IN G. 
NORIviAL SKIN ANAESTHETISM SKIN 
N. F.SY. H. 10-6 + 0 
10-5 + 0 
l0-4 + + 
I.G.H. 10-5 + 0 
A. C. P. 5 X 10-4 + + 
O.D. 10- 0 0 
10 -4 + 0 
5 x 10 -4 0 
D.1.,. C. 10-7 + 0 
10- + 0 
10-5 + 0 
10-4 + + 
J.A.P. 10--5 0 0 
10 L + + 
T.M. C. 10- + + 
S. J. 10-4 + + 
J.K.R. 106 + 0 
10-5 + 0 
H. 10-4 + + 
J. R. 10-4 + + 
A.A.G.L. 10-if + + 
Table 19. Subject R.B.R.R. 
Effect of Reflex Heating on Response to Ach 
Time Concentration Electrical Readings (Micro- Skin Temp. (IF) 





















3.00 Feet in Hot Water 
3.10 10 -5 0 0 30.5 23.5 
3.20 10-5 0 0 31.0 28.0 
3.30 10-5 0 0 32.0 30.0 
3035 10 
-5 
0.3 0.3 33.5 32.5 
(Sweating became profuse between 3.35 and 3045) 
3.45 - - 3.0 - - 
Table 20 
Effects of intradermal injection of anticholinesterase drugs 






Neostigmine Eserine TEPP Nu 683 Ro 30340 
+ - - - - 











+ - + 0 0 
i'F...PP = tetraethylpyrophosphate. 
Nu 683 = dimethylcarbamic ester of 5- phenyl- 2- hydroxylbenzyl- 
trimethylammonium bromide 
Ro 30340 = m- dimethyl amino phenyl diethyl phosphate -methyl methyl 
sulphate. 
All drugs given in saline in a concentration of 10 
-4 
, except TEPP 
(10 -3 in propylene glycol.) 10 
-4 
TEPP gave a minimal sweat response 
in subject B.A.S. on one occasion and no response on another occasion. 
10 -3 TEPP also caused sweating in two normal subjects 0.P. and G.L.P.) 
after the glands had been isolated by procaine block of the cutaneous 
nerves. 
Table 21 Subject G.L. SAP. 
Effect of Intradermal Atropine on Response to Adrenaline. 
Adren. 
10-4 









100 5.0 60 7.0 
Atropine 10-4 (0.05 cc.) 20 mins. before Adren. 
Table 22. 
Threshold concentrations (to produce sweating) of 
1- adrenaline dl- noradrenaline and acetylcholine, 
(Intradermal in 'ection in forearm.) 
óubject 1-adrenaline dl-noradrednaline Acetylcholine 
G.L.S.P. 10-7 10-6 - 5 x 106 
G.M. 10-I+- 10-4 10-4 
E.P.S. 10-6 10-41. 10-5 
J.O. 10-3 No response 
to 103 
10 -3 




No resp nse 
to 10- 
No resgonse 
to 10 2 
A:A.G.L. 10-5 Not tested 105 
J.K. 10-6 _ 10-5 
M. K.11 10-4 - 10-4 
G. S. 10-5 - 10-I+- 
J.B.L.H. 
No response 
to 10- - 10-3 
F.H. 10-5 - 10 6 
In subject M.K.M mixtures of adrenaline and A Ch. were tried. 
No potentiation was detected. 
Table 23 Subject G. L. S. P 
Effect of Intradermal 10- Dihydro- ergocornine (DHO) on 
Sweat Responses to acetylcholine and adrenaline and to 
Reflex Heating 
STIMULUS 









ACh. 10-6 - - 0 0 
10-5 1 0.6 6 1.7 
10"4 4. 0.8 4-2 5.5 
Adren.10 -6 
10-1+ 
0 0 7 1.1. 
0 0 4.0 5.0 
Reflex 
heating 
- 2 -4. - 6 -8 
Table 24 Subject G.L.S.P 
Effect of Louer Concentrations of Intradermal Dihydróergocornine 
(DHO) on Responses to Adrenaline, ACh and Reflex Heating. 















Skin 30 2.5 
over 
50 5.0 6 1.2 3 -6 micro- 
amps. 
3.5 DHO 10 
-6 4 0.6 20 2.0 - - 
DHO 10 75 0 0 27 2.0 12 2.0 3.2 
DHO 1074 0 0 25 1.4 a - 4.5 





Effect of Intradermal 10-4 Dihydroergocristine (DCS) on 
Response to Adrenaline 









0 ABSENT 11 PRESENT 
22 PRESENT 35 PRESENT 
Table 26 - Subject J.M. 
Adren.l0-5 
Effect of Intradermal dibenamine 5 x 10 -2 on the 
Response to Adrenaline 
With dibenamine Without dibenamine 










25 2.6 2+ 3.2 PRESENT 




Effect of pimElly1 methyl benzodioxane (933 F) 10-3 
on the Response to Adrenaline . 
With 933 F 
°. 
Without 933 F 


















Table 28. Subject J.M. 
Effect of Intradermal benzylimidazoline ( Priscol) on the 













30 PRESENT 44 PRESENT 8 -12 mi.croamp- 
- - PRESENT - 
9 ABSENT 37 PRESENT - 
_ - 5 JUST 
VISIBLE 
_ 
- - 15 microamps 
Table 29 
Stimulation of palmar sweat glands by intradermal adrenaline. 







10_6 50 -100 








Effect of Intradermal Dihydroergocornine (DHO) and atropine on 
Palmer Sweat Glands in a Case of Hyperhidrosis (A,E.). The 






ACh. 10 -5 Adfen 10 

















1,5 micro - 
ames. 
14. - 16 - 
0 1.5 0 1.5 ]4 - 16 
Atropine was injected at two different sites, 
only one of which was used for subsequent ACh 










































































































































































































































































































































































































































































































































































































































































































Threshold concentration for stimif ation of palmar sweat 




B.F 10®4 I.G.H. 10`3 
Gr.S 10 -5 A.C.P. 10-4 
S.C. 10 
-6 
A< A :. L. 10 
-5 
I.S. 10l7 G. du B. 105 
Gi.S. 10'7 J.R. 10-7 
B.A.S. 10 
-8 
G.P.B. 10 -7 
J.A.F. 10-7 
T.M.C. 108 
The glands were first isolated by procaine block of 
the median nerve. 
Table 33 
Effect of intravenous atropine on palmar sweating, salivation 











0 over 24. micro- 
amps 
78 /MIN 1.70 GM. 
0.4. mg. over 24 82 1.55 
0.6 6.0* 108 0.20 
0.8 5.0 3i 114. 0 
.1 
Hands felt dry 
Table 34. 
Effect of Pentamethonium Bromide on Heart Rate, Blood 
























Electrical Readings (Micro 
s. 
R.Palm L.Palm. 


































































Effect of Pentamethonium Bromide on Blood Pressure: Heart 
Rate and Sweatin: in a Case of -y. erhidrosis. J.S. 




Electrical Readings on 
Palm (Micro- amps.) 
Right Left 
10.03 Recumbent 96 145 /100 21f 22 
.17 90 345/100 Over 24 22 
.25 96 345/100 19 22 
.33 86 114.0 /100 15 23 
.38 92 345/100 15 15 
.39 Pentamethonium Bromide 10 mgm. I.V. 
.41 r Over 24 22 
.42 98 1+5/l00 21 21 
++ 96 140/95 15 19 
.46 96 140/95 12 17 
.48 96 140/95 12 17 
.49 Pentamethonium Bromide 10 mgm. I.Y. 
.51 16 19 
.52 96 135/90 12 16 
.54. 96 135/95 5.5 15 
.56 96 135/95 3.5 12 
.58 96 11aÁ/loo 2.5 9 
1.02 96 14q/loo 2.5 8 
Continued overleaf: 
l' 
Table 35 - Continued 




Electrical Readings on 
Palm (Micro-amps) 
Right Left 
11.05 sitting 120 160/115 4 7.5 
. .07 120 155/110 2 2 
.10 120 155/110 3 3 
.12 legs down 124 345 /105 5 9 
.16 86 135/100 2 8 
.20 108 130/100 2 8 
.27 Standing 120 140 /100 9 12 
.38 112 140/105 7 7 
12.00 - 19 
No Symptom. 
Table 36 
Effect of Pentamethonium Bromide on Heart Rate, Blood Pressure 
and Sweating in a Case of Hyperhidrosis (A.E.) 




Electrical Readings (Micro -.. 
Palms Soles 
Right Left Right Left 
12.15 Recumbent 100 115/65 19 24. 
.25 98 105/65 13 20 15 16 
.32 100 105/60 11E. 19 15 18 
.34 Pentamethonium Bromide 10 mgm. I.V. 
.35 100 100/55 15 23 18 20 
.37 102 100/55 15 22 14 20 
.39 96 100/60 12 18 13 19 
.41 96 100/65 9 16 11 17 
43 98 100/65 9 19 11 17 
.4.6 94 105/65 12 18 10 16 
.48 Pentam #thonium Bromide 10 mgm. I.V. 
.49 94. 1Q0/65 12 15 .7 15 
.51 96 95/60 5 12 6 13 
.55 94 95/65 4 11 4 12 
.56 Sitting No symptoms. 
.57 110 105/80 
.59 116 100/80 3 3 12 
Continued overleaf: 
Table 36 - Continued 
Time Posture heart Rate 
(Per min.) 
B.P. 
( mm.Hg. ) 
Electrical Readings (Micro - 
amps) 
Palms Soles 
Right Left Ri: t Left 
1.02 Standing: Faint and dizzy 
.03 120 50/? 
.06 Walking: - 50/? 3 11 4. 12 
.07 Recumbent No symptoms 
.08 100/60 
.13 92 100/60 1 3 2 10 
.15 Sitting Dizzy. 
.16 Recumbent No symptoms 
.35 84 100/60 0.5 2.5 2.5 8 
.37 Sitting No symptoms 




Effect of Pentamethonium Bromide on Heart Rate, Blood Pressure 

















































.11 Sitting No Symptoms 
.13 100 




.20 Walking No symptoms 
.21 I - 
24. over 2)4- 
11 15 
16 20 
















































6 7 8 
ACTUAL DILUTION 
NEGATIVE LOGARITHMIC SCALE 
9 
Fig. 1. To show the error involved in making dilutions 
of kch with a single syringe (plotted vertically) instead 
of with separate pipettes. Solutions were compared on the 
frog rectus abdominds muscle (by Dr. F.Hobbiger with accurate 
dilutions made up with a series of graduated pipettes and flasks. 
Fig.2. TIME - COURSE OF RESPONSE TO ACh 10 
"3 





10 20 30 40 50 
MINUTES AFTER INJECTION 
Fig.2. Subject ßú.R. The drugs were injected intradermally at 
comparable sites in the same forearm. The electrical reading 
is the current flow through the skin at the site of injection. 








0 0-3 0.6 0.9 1.2 I.5 I.8 2I 2.4 
ATROPINE MGM. I.V. 
F.T.O. 
Fig.3. Subject H.J.R. In the experiments illustrated in figs.3 
and 4 atropine was given by increments of O.3mgm I.V at 5 min. 
intervals. The dotted line represents the current flow through 
the palmar skin. The unbroken line is the sensitivity of the 
forearm sweat glands to intradermally injected ACh. It is not 
po is ble to make both observations simultaneously in the same 
site because (1) in the forearm, when spontaneous sweating is 
absent, the inhibitory effect of atropine on neuro- effector 
transmission cannot be observed. (2) in the palm, the response 
to injected ACh is obscured by spontaneous sweating. :',hen this 
is eliminated by procaine block of the median nerve, the palmar 
glands are found to be rather more sensitive to ACh than those 
on the forearm. (Table 4). 
GP B. Fig. 4. ATROPINE Vs PALMAR SWEATING AC1, THRESHOLD 
IO IOZ 
8 10-3 
6 10 4 





2 0 03 06 09 12 IS 1.8 2.1 24 a 





Fig. 4. Subject G.P.B. See legend to FiF. 3. 
ACh THRESHOLD 
- -- ------ . - - ---a SWEATING 




.P' L 10-3,_ ATROPINE I0 -5 
O 4 10 12 14 
MINUTES 
16 18 20 22 24 
Fig. 5. Subject G. du B. The drugs were injected intradermally 
in the forearm. 
9,6. INTRAVENOUS DOSE OF ATROPINE PLOTTED /AGAINST LOCAL 
CONCENTRATION REQUIRED TO PRODUCE THE SAME PERCENTAGE 








03 0.6 O.9 I.2 1.5 1.8 2.1 
DOSE OF INTRAVENOUS ATROPINE MGM) 
Fig.6. Ln idealised graph derived from data in figs.3 and 4 
and Table 17. The effect of intravenous atropine was observed 
in the palm: that of intradermal atropine in the forearm. 
FIg.7 O.D. RELEASE OF ACh. BY SWEAT NERVE-ENDINGS DURING REFLEX 























Fig.7. 0.2 cc. of 10 -5 neostigmine injected intradermally in 
the forearm. At 0 both feet in water at 45 °C. The broken 
line represents current flow through the treated skin, the 
other being the flow through adjacent areas of skin. 
Fig.8. EFFECT OF INTRADERMAL ATROPINE AND DHO ON THE 
RESPONSE TO REFLEX HEATING. 
P.T.O. 
Fig.8. Subject G.S.P. Atropine (ATP) and dihydroergocornine 
(DHO) were injected intradermally'(volume 0.2 cc), and sweating 
induced by heating tike feet. The skin has been dusted with 
Q,uinizarin powder to show that sweating has been inhibited by 
atropine but not by LHD. 
S.C. EFFECT OF PENTAMETHONIUM BROMIDE LV. ON PALMAR PLANTAR 























e ---. LEFT 
Yr -X RIGHT 
.- --- LEFT 
B.P ,Hc6. 
125 




Fig. 9. At 20 mins., and again at 32 mins., 10 mgm. of 
Pentamethoniun Bromide was injected intravenously with the 
subject recumbent. At 44 mins. she sat up, then stood up. 
Note the marked inhibition of plantar sweating without 
postural hypotension. 
